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1 Abstract 
 
 
Listeria monocytogenes, a gram-positive, facultative intracellular 
pathogen, is the causative agent of many severe foodborne diseases 
in humans. Once in the intestinal tract of humans, the Listeria surface 
protein Internalin A (Inl A) interacts with its receptor E-cadherin and 
the bacterium is taken up by the intestinal epithelial cell. The mouse 
E-cadherin differs from its human homologue by a single amino acid 
exchange that strongly reduces the affinity to Inl A.  To enable oral 
infection studies with moderate Listeria doses in the mouse model, 
our aim was to create a murinized L. monocytogenes LO28 strain. 
Therefore we tried to replace the  truncated LO28 Internalin A gene 
with a mutated version of the  Internalin A gene from the L. 
monocytogenes EGDe strain. 
In addition to the uptake into intestinal epithelial cells, Listeria can be 
taken up by macrophages. Once recognized, many signaling 
pathways are triggered in the cell, leading amongst others  to type I 
IFN gene induction. We investigated the role of the signal transducers 
TBK1, p38 MAPK, IKKβ and JNK in the induction of IFN-β. Since IFN-β 
production increases  host cell death, the impact of these signal 
transducers on the death of Listeria infected macrophages was 
studied as well. Our data suggest that all proteins are needed for full 
IFN-β induction, but IKKβ inhibition showed the slightest effect. 
Concerning the cell death, only p38 MAPK and JNK seem to have an 
impact.  
Interferons subsequently induce STAT-JAK signaling. We examined 
the role of Stat1 F77A macrophages, which are unable to form Stat1 
oligomers due to the aminoacid substitution in the N-terminus, on the 
intracellular replication of Listeria. Further, we analyzed gene 
induction and cell death in Stat1 F77A macrophages. 
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Our results show that Listeria replication is altered  in Stat1 F77A 
macrophages compared to wild type cells. In the mutant cells, the 
induction of Stat dependent genes is strongly decreased. We could 
not observe a difference concerning host cell death in the Stat1 F77A 
macrophages.
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2 Zusammenfassung 
 
 
Listeria monocytogenes ist ein gram-positives, fakultativ 
intrazelluläres Humanpathogen, das für viele schwerwiegende 
Lebensmittelinfektionen im Menschen verantwortlich ist. 
Wenn sich Listerien im Verdauungstrakt des Menschen befinden, 
interagiert deren Oberflächenprotein Internalin A (Inl A) mit dem 
Rezeptor E-Cadherin, wodurch die Bakterien von den 
Darmepithelzellen aufgenommen werden.   
Der E-Cadherin Rezeptor in der Maus unterscheidet sich vom 
menschlichen durch einen Aminosäureaustausch, der die Affinität zu 
Inl A reduziert. Um orale Infektionen mit einer angemessenen Dosis 
an L. monocytogenes LO28 im Maus Model zu ermöglichen, muss die 
Interaktion zwischen Internalin A und E-cadherin funktionieren.  
Deshalb sollte hier das trunkierte Inl A Gen des Stammes LO28 durch 
ein vollständiges Gen des L. monocytogenes EGDe Stammes erstezt 
werden, das zusätzlich Mutationen zur Erhöhung der Affinität zum 
Maus E-Cadherin trägt.   
Zusätzlich zur Aufnahme in Darmepithelzellen können Listerien auch 
von Makrophagen aufgenommen werden. Einmal vom Immunsystem 
erkannt werden viele Signaltransduktionswege angeschaltet, die 
unter anderem zur Produktion von Typ I Interferonen führen.  
Wir untersuchten die Rolle der Signaltransduktionsmoleküle  
TBK1, p38 MAPK, IKKβ und JNK bezüglich IFN-β Induktion und auch 
den Tod infizierter Makrophagen, da IFN-β nekrotischen Zelltod 
verstärkt.  Unsere Daten zeigen, dass alle Proteine für eine 
vollständige IFN-β Induktion notwendig sind, wobei IKKβ Inhibition 
den geringsten Effekt aufweist. Bezüglich des Zelltods spielen nur p38 
MAPK und JNK eine Rolle.  
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Interferone sind weiters verantwortlich für die Aktivierung des JAK-
STAT Signaltransduktionsweges. Wir analysierten die Auswirkung 
einer Stat1 F77A Mutation auf die intrazelluläre Vermehrung von 
Listerien. Aufgrund der Mutation im N-Terminus ist eine 
Oligomerisierung von Stat1 F77A Molekülen nicht mehr möglich. 
Weiters untersuchten wir die Geninduktion und den Zelltod von 
Listerien infizierten Stat1 F77A Makrophagen.  
Unsere Ergebnisse zeigten einen deutlichen Effekt der Stat1 F77A 
Mutation auf die intrazelluläre Vermehrung von L. monocytogenes. 
Weiters konnten wir zeigen, dass die Induktion der untersuchten, 
durch Interferon induzierten, Gene stark vermindert ist. Bezüglich des 
Zelltodes konnten wir keinen Unterschied zwischen mutierten und 
Wildtyp Makrophagen feststellen.  
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3  Introduction 
 
 
3.1 Listeria monocytogenes 
 
Listeria monocytogenes is a gram-positive facultative intracellular 
bacterium. It is the etiological agent of listeriosis, a severe human 
foodborne infection, characterized by diseases like febrile 
gastroenteritis, meningitis, encephalitis, sepsis, abortions and 
perinatal infections (Dussurget et al., 2004).  
In addition, L. monocytogenes causes infections in a variety of other 
vertebrates, including domesticated and wild birds and other 
mammals. 
Listeria can be found throughout the environment in soil, vegetation 
and animals, but contaminated food is the major source of infection 
in epidemic, as well as in sporadic cases. Therefore the 
gastrointestinal tract is thought to be the primary site of entry into 
the host. Usually, the clinical course of infection starts about 20 hours 
after the ingestion of heavily contaminated food in cases of 
gastroenteritis, whereas the incubation period for the invasive illness 
is generally around 20 to 30 days (Allerberger and Wagner, 2010; 
Vázquez-Boland et al., 2001). 
 
 
 
3.1.1 Life cycle of Listeria monocytogenes 
 
Listeria monocytogenes can invade and replicate in a variety of cell 
types including epithelial cells and macrophages. After entry the 
bacterium lyses the internalization vacuole and escapes into the 
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cytoplasm of the host cell, where the bacteria start to replicate. When 
the bacterium is in the cytosol, it uses an actin based motility process 
to move through the cytosol and to invade neighbouring cells through 
the formation of a double-membrane protrusion, which results in the 
formation of a so-called secondary vacuole. Afterwards this 
compartment is lysed, making a new intracellular infection cycle in 
adjacent cells possible (Dussurget et al., 2004). 
 
 
 
Figure 1: Life cycle of L. monocytogenes. The pathogen can survive in different 
environments. The transcriptional activator PfrA plays an important role in the switch 
between life outside and inside of host cells. On the right hand side the life cyle of L. 
monocytogenes is shown (Freitag et al., 2009). 
 
 
Two molecules, Internalin A (InlA) and Internalin B (InlB), mediate 
the bacterial invasion into target cells. These proteins belong to the 
internalin family, characterized by the presence of leucine-rich 
repeats (LRRs), which are involved in protein-protein interactions. 
Two LRR regions are separated by an inter-repeat region (IR). These 
regions are necessary and sufficient to promote Listeria entry into 
human epithelial cells. 
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The receptor for the 800-amino acid protein InlA is called E-cadherin 
and belongs to the cadherin superfamily of cell adhesion molecules. 
The 882 amino acid transmembrane protein consists of a long N-
terminal extracellular domain, a transmembrane domain and a 
relatively short cytoplasmic domain.  
The ectodomain of E-cadherin is required for bacterial adherence but 
also the intracytoplasmic domain is absolutely necessary for entry of 
microbes into the host cell, because its phosphorylation regulates the 
binding of E-cadherin to its interactors (Bonazzi et al., 2009; 
Dussurget et al., 2004). 
The interaction of InlA and E-cadherin is species specific and will be 
discussed in chapter 3.1.3. 
 
InlB (630 amino acids) is located in the same operon as InlA. The two 
proteins can be transcribed bicistronically or alternatively, InlB 
expression can be regulated independently via σB. InlB is essential 
for entry of Listeria monocytogenes into many cell types, for example 
hepatocytes and other nonepithelial cells.  
The hepatocyte growth factor/scatter factor, also called Met, has been 
identified as the main receptor for InlB. Met belongs to the family of 
tyrosin kinase receptors. InlB binds Met through the concave surface 
of the LRR region, which leads to transient phosphorylation of Met 
(Bonazzi et al., 2009a; Dussurget et al., 2004). 
 
After invasion of host cells, Listeria resides in a vacuole that is lysed 
by Listeriolysin O (LLO) in concert with two phospholipases C (PLCs). 
LLO is a member of the pore-forming, cholesterol-dependent 
cytolysin family.  When Listeria is located in the cytoplasm, it starts 
to multiply and moves by polymerizing the host cell actin through the 
activity of the virulence factor ActA. Actin based motility allows 
Listeria to spread from an infected cell into adjacent cells after the 
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transient formation of a double-membrane vacuole, which is then 
lysed by the activities of LLO/PLC (Dussurget et al., 2004). 
Mutants lacking LLO fail to reach the cytoplasm and are nonvirulent 
(Portnoy et al., 2002). 
 
Cytosolic LLO is degraded by the N-end rule pathway, restricting its 
function to the vacuolar environment and inhibiting the lysis of host 
cells (Dussurget et al., 2004; Schnupf et al., 2007). 
The pH for optimal pore formation by LLO is between 5,5 and 6,0 (the 
pH of the early phagosome). 
Listeria secretes two PLCs, which also play a role in the lysis of 
intracellular vacuoles. The PI-PLC is specific for phosphatidylinositol 
(PI) and glycosyl-PI-anchored proteins, whereas the 
phosphatidylcholin (PC)-PLC is a broad range PLC. The PC-PLC can 
also promote lysis of primary vacuoles in human epithelial cell lines, 
when LLO is absent. Together with LLO, the PI-PLC induces hydrolysis 
of PI and production of diacylglycerol in macrophages (Dussurget et 
al., 2004). 
Mutants lacking both PLCs show a defect in vacuolar escape (Portnoy 
et al., 2002). 
 
Cytosolic Listeria move through the cytoplasm by polymerization of 
actin filaments. This ―motor‖ makes it possible to spread from one 
cell to another adjacent cell. The surface protein ActA is the only 
bacterial factor required for this activitiy. The Listeria actin-based 
motility is stimulated by a central repeat domain containing four 
proline-rich repeats. This domain binds members of the 
enabled/basodilator-stimulated phosphoprotein family of proteins. 
These molecules modulate bacterial speed and directionality.  
The amino-terminal region of ActA is the only important region for 
inducing bacterial movement. It binds and activates Arp2/3, a seven 
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protein host complex, which induces actin polymerization and the 
generation of a dendritic array of actin filaments (Dussurget et al., 
2004). 
ActA minus mutants are not able to spread from cell to cell or to form 
plaques in tissue culture monolayers (Portnoy et al., 2002). 
Listeria moving at the tip of actin-comet tails can form protrusions 
that are engulfed by neighboring cells. 
 
The most important Listeria virulence genes are regulated by the 
transcriptional activator PrfA, which belongs to the Crp/Fnr family. At 
temperatures of about 37°C, the temperature of the host, PrfA 
regulated virulence factors are produced at higher levels. At 
temperatures lower than 30°C, the low levels of expression of 
virulence genes are correlated to undetectable levels of PfrA, 
although its transcript is synthesized. At low temperatures, the 
untranslated leader region of the prfA messenger RNA forms a stable 
secondary structure (called a thermosensor) masking the Shine-
Dalgarno sequence, which averts the translation of PfrA. This 
thermosensor melts at higher temperatures, resulting in the 
translation of PrfA (Dussurget et al., 2004). 
 
 
 
3.1.2 Listeria monocytogenes strains 
 
The species L. monocytogenes comprises 13 serovars, but only 
serovars 1/2a, 1/2b and 4b are responsible for 98% of listeriosis 
reported in humans (Dussurget et al., 2004; Sleator et al., 2009). 
In our lab, we are mainly using L. monocytogenes EGDe (serovar 
1/2a) and LO28 (serovar 1/2c), which are both fully virulent in the 
mouse model.  
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One crucial difference between these two strains is a nonsense 
mutation in the inlA gene of LO28. In Listeria LO28, the adenine at 
position 1637 is deleted, resulting in a frameshift, creating a stop 
codon (TAA) at position 1729. This leads to a truncated version of 
InlA, lacking a cell wall anchor.  
Western blot analysis showed that the amount of InlA found in whole 
cell extracts of EGDe and LO28 was quite similar, but for LO28 
cultures a larger quantity of InlA could be found in the supernatant 
than in EGDe supernatants, due to the absence of a cell wall 
anchoring motif (Jonquières et al., 1998).  
These findings would suggest that in vivo infection with Listeria 
monocytogenes LO28 is not as effective as infection with EGDe, due 
to the lower amount of InlA found on the Listeria LO28 cell wall, that 
is important for InlA/E-cadherin interaction, leading to uptake into 
intestinal cells. 
 
Also important for our studies is the fact, that Listeria monocytogenes 
LO28 induces an about 10 times stronger type I interferon response 
in infected bone marrow derived macrophages (BMDMs) and bone 
marrow derived dendritic cells (BMDCs) as well as in RAW 264.7 
macrophages compared to the strain EGDe (Reutterer et al., 2008).  
 
 
 
3.1.3 Species specificity of InlA E-cadherin interaction 
 
InlA specifically interacts with the N-terminal EC repeat of E-cadherin, 
termed EC1. This interaction is species specific, for example in rat 
and mouse it is completely impaired, whereas the interaction between 
InlA and E-cadherin is intact in humans, guinea pigs and gerbils. 
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This species specificity is due to a single aminoacid within the EC1 
domain of E-cadherin. Species allowing an interaction harbor a prolin 
at position 16 of the EC-1 domain, whereas in mice and rats there is 
a glutamic acid (Bonazzi et al., 2009b; Lecuit et al., 1999). 
 
Prolin at position 16 makes the loop hydrophobic and uncharged, 
whereas the glutamic acid in the E-cadherin loop results in a charged 
and hydrophilic region. Therefore it is obvious that InlA E-cadherin 
interaction is dependent on hydrophobic interactions at this position. 
However this is not sufficient for InlA binding to the EC1 domain of 
cadherins, as InlA does not interact with N-cadherin, where prolin is 
also located at position 16. In 2002 the crystal structure of InlA alone 
and in complex with E-cadherin was solved, showing a hydrophobic 
binding pocket in the InlA molecule, which creates the binding site for 
E-cadherin. 
 
The affinity of InlA to E-cadherin is not very high, which could be an 
advantage for the bacterium, as InlA has to dissociate from the 
receptor once the bacterium has been internalized.  
 
To solve the interaction problem of Listeria InlA and the mouse E-
cadherin, either the bacterium or the mouse have to be modified. 
Both scenarios have already been put into practice. On the one hand, 
a murinized Listeria strain has been created and on the other hand 
there is a humanized mouse (see Figure 2) (Bonazzi et al., 2009b).  
 
The transgenic mouse expressing human E-cadherin at the level of 
the intestine, allowed InlA-mediated intestinal Listeria infections in an 
animal model for the first time, providing evidence that InlA, but not 
InlB, is the molecule necessary for crossing the intestinal barrier after 
oral infection (Bonazzi et al., 2009b; Lecuit et al., 2001). 
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Some years later the murinized Listeria monocytogenes strain EGDe 
was created (Wollert et al., 2007). Serine at position 192 was 
replaced by asparagine, bridging the gap between InlA and E-
cadherin and tyrosin 369 substituted by serine allows the formation of 
a hydrogen bond. Changing these two aminoacids increases the 
affinity of InlA to the murine E-cadherin by four orders of magnitude, 
which is comparable to the affinity of the unmodified InlA with human 
E-cadherin.  
These two substitutions extend the binding specificity of InlA to 
include formerly incompatible murine E-cadherin, by creating 
additional, stabilizing contacts (Bonazzi et al., 2009b; Wollert et al., 
2007).  
 
Figure 2: Model systems for analysis of L. monocytogenes infection in mice. A. InlA is 
unable to bind to the E-cadherin of the mouse. B. Human E-cadherin is expressed in 
transgenic mouse – interaction InlA/E-catherin is possible. C. InlA is modified via 
rational protein engineering – interaction InlA/E-cadherin is possible (Sleator et al., 
2009; modified figure). 
 
 
Listeria 
mouse intestinal 
epithelial cell 
Listeria 
Listeria 
no invasion invasion invasion 
A. Normal 
Mouse 
B. Humanized 
mouse 
C. Murinized 
pathogen Lecuit et al., 1999 Disson et al., 2008 Wollert et al., 2007 
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3.1.4 Innate immune response to Listeria monocytogenes 
infection 
 
After infection with Listeria monocytogenes, innate immune 
responses are rapidly activated and are essential for controlling 
bacterial growth and dissemination and preventing spreading of the 
pathogen, which could result in systemic lethal infection.  
Early resistence is due to the action of phagocytes. Neutrophils can 
kill bacteria through engulfment and resulting production of reactive 
nitrogen and oxygen intermediates and extracellular bacteria through 
release of extracellular traps.  
Neutrophils secrete chemokines, like MCP-1, and cytokines, like CSF-
1, which are necessary for recruitment of macrophages to the site of 
infection. 
In response to infection, macrophages secrete cytokines like tumor 
necrosis factor α (TNFα) and interleukin 12 (IL-12) which induce the 
secretion of interferon γ (IFN-γ) by natural killer cells (NK-cells), 
resulting in the enhanced activation and bactericidal activity of 
macrophages.   
Also in macrophages the production of reactive oxygen and nitrogen 
intermediates plays an important role in the clearing of the bacteria 
(Zenewicz and Shen, 2007).  
Innate immune responses are activated stepwise. Listeria are 
recognized by specific receptors and downstream signaling cascades 
are activated. TLR2 and TLR5 seem to play a role in recognition of 
extracellular Listeria (Pamer, 2004). Nucleotide-binding 
oligomerization domain 2 (NOD2) and NACHT/LRR/PYD-containing 
protein 3 (NALP3) are important for recognizing intracellular Listeria, 
but the receptor, triggering tank binding kinase 1 (TBK1) and IκB 
kinase ε (IKKε or IKKi) activation and subsequent IFN-β induction is 
still unknow (Zenewicz et al., 2007).  
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Recently, the protein LRRFIP1 was identified as cytoplasmic nucleic 
acid sensor, mediating IFN-β induction in response to 
L.monocytogenes infection. LRRFIP1 signals via β-catenin and 
subsequent activation of IRF3. Nevertheless, it does not affect PRR-
triggered activation of IRF3 or NFκB (also see chapter 3.3.2) (Yang et 
al., 2010). 
Type I interferons, usually associated with antiviral immune 
responses, are important for clearing of many viral pathogens. 
Concerning Listeria monocytogenes infection, type I interferons are 
detrimental for the host.Previous studies have shown that the 
induction of type I interferons decreases the viability of Listeria 
infected host cells. Mice that lack the receptor for type I interferons 
have increased resistance to Listeria infection (Pamer, 2004; 
Reutterer et al., 2008; Stockinger et al., 2002, 2009). 
 
 
 
3.1.5 Cell death of eukaryotic cells after L.monocytogenes 
infection 
 
Many pathogenic microorganisms are able to cause eukaryotic cell 
death, either as a consequence of infection or via production of toxic 
products. 
The diversity of processes mediating cell death necessitated the 
introduction of several terms for the different ways a cell can die. 
Three of the best characterized cell death types are probably 
apoptosis, necrosis and pyroptosis. 
 
Apoptosis is described as an active, programmed cell death. Apoptotic 
cells show autonomous cellular dismantling that avoids inflammation. 
  
Introduction   15 
 
 
Necrosis is a passive, accidental cell death resulting from 
environmental perturbations. Necrosis leads to release of 
inflammatory cellular content. 
Pyropotosis is characterized by caspase-1 activation, which processes 
the pro-forms of the inflammatory cytokines, IL-1β and IL-18. 
Pyroptosis features cell lysis and also releases inflammatory cellular 
contents (Fink and Cookson, 2005).  
 
Earlier studies in our lab showed that Listeria monocytogenes induced 
cell death of macrophages is best classified as necrosis. This 
conclusion could be drawn due to the cellular morphology and the 
lack of requirement for typical events necessary for other cell death 
types, like caspase activation and loss of the mitochondrial membrane 
potential (Zwaferink et al., 2008).  
One important aspect of Listeria induced cell death is the ability of 
type I IFNs to increase the death of infected macrophages via an NO-
dependent enhancement of necrosis (Stockinger et al., 2002; 
Zwaferink et al., 2008).  
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3.2 Macrophages 
 
Macrophages are cells of the innate immune system. They originate 
from stem cells in the bone marrow, circulate in the blood as 
monocytes and differentiate into macrophages when they enter 
organs such as the liver (Kupffer cells), the central nervous system 
(microglia) or the lung (alveolar macrophages). According to the 
requirements of the tissue, their  morphology and functions differ 
(Abbas, 2010; Takahashi, 2001). 
Their main function is to recognize invading microorganisms, 
phagocytose and kill the microbes. For this purpose macrophages 
express pattern recognition receptors (PRRs), which sense general 
structures of microbes called pathogen associated molecular patterns 
(PAMPs) (see chapter 3.3).  Activation by IFN-γ is of vital importance 
to enhance macrophage effector functions. This cytokine is secreted 
by NK cells in response to activating ligands on the surface of infected 
host cells or in response to IL-12.  Activated macrophages produce 
cytokines, which are necessary for inducing an inflammatory reaction, 
stimulate and recruite other cells, like T-cells and NK-cells and 
produce growth factors for fibroblasts and endothelial cells that 
participate in the remodelling of tissue after infections and other 
tissue injuries.  Macrophages typically respond very early to microbes 
and because of their long survival at sites of infection, they are the 
dominant effector cells at later stages of the innate immune response 
(Abbas, 2010). 
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3.3 Pattern Recognition Receptors 
 
The innate immune system possesses a limited number of germline-
encoded PRRs, which are important for the recognition of invading 
microorganisms. Concerning their location it can be distinguished 
between three main classes of PRRs: PRRs located on the cell surface, 
(TLRs), receptors in the endosomal membrane (TLRs) and 
cytoplasmic PRRs.  
All receptors have in common that they recognize microbial 
components, so called PAMPs, which leads to the activation of 
signaling pathways and further induces the expression of a variety of 
genes (Akira et al., 2006). 
 
 
 
3.3.1 Toll like receptors 
 
TLRs are type I integral membrane glycoproteins and defined by the 
presence of a Toll/interleukin-1 (IL-1) receptor (TIR) domain in their 
cytosolic regions, which is necessary for the signal transduction, and 
an extracellular leucine-rich repeat region that plays an important 
role in the recognition of microbial by-products (Dunne and O'Neill, 
2005; O'Neill, 2003). 
Up to date 13 members of the TLR familiy have been identified in 
mammals. 11 could be found in humans and 13 in the mouse genome. 
TLRs1-9 are conserved in both species (Dunne et al., 2005). 
TLRs are expressed on many immune cells, including macrophages, 
dendritic cells, B cells, specific types of T cells and also on non 
immune cells such as fibroblasts and epithelial cells (Akira et al., 
2006). 
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Cell surface stainings with antibodies to specific TLRs revealed that 
TLR1, TLR2, TLR4, TLR5 and TLR6 are localized on the plasma 
membrane whereas TLR3, TLR7, TLR8 and TLR9 are preferentially 
expressed in intracellular compartments such as the endosome. 
The latter group of TLRs recognizes nucleic acid structures whereas 
TLR1, TLR2, TLR4, TLR5 and TLR6 generally recognize cell wall 
components of microorganisms (Dunne et al., 2005). 
 
 
 
3.3.2 Cytoplasmic receptors 
 
When pathogens bypass the membrane-associated PRRs and invade 
the cytoplasm, they are detected by cytosolic receptors (Akira et al., 
2006; Lee and Kim, 2007). 
Cytoplasmic PRRs can be classified into three different families: 
interferon (IFN)-inducible proteins, caspase-recruiting domain (CARD) 
helicases and NOD-like receptors (NLRs). IFN-inducible proteins such 
as double-stranded RNA (dsRNA)-dependent protein kinase (PKR) or 
2',5'-oligoadenylate synthetase 1 (OAS-1) and CARD helicases are 
mainly important in antiviral defense, whereas NLRs primarily 
mediate antibacterial defense (Lee et al., 2007; Behera et al., 2002). 
 
PKR is a ubiquitously expressed serine-threonine kinase that is 
dramatically induced by IFN-γ. At the N-terminus two dsRNA-binding 
domains can be found and a conserved kinase domain at the C 
terminus. Once activated by dsRNA, PKR dimerizes, 
autophosphorylates and in turn phosphorylates the α-subunit of 
eukaryotic initiation factor 2 (eIF-2), leading to decreased protein 
synthesis in mammalian cells (Hu et al., 2009; Kumar et al., 1994). 
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Retinoic acid-inducible protein I (RIG-I) and melanoma differentiation 
associated gene 5 (MDA5) are cytoplasmic helicases containing a 
CARD domain.  
They play an important role in detecting viruses that enter the cytosol 
of cells, or viral RNA synthesized in the cytosol (Andrejeva et al., 
2004). Both receptors are able to recognize dsRNA via their RNA 
helicase domain. Furthermore they have two CARDs, which are 
critical for initiating downstream signaling pathways (Lee et al., 2007). 
LGP2 (laboratory of genetics and physiology 2) is also a RIG-I like 
helicase that can recognize RNA. Unlike RIG-I and MDA5, LGP2 lacks 
the CARDs and thus has no signaling capability (Li et al., 2009; Murali 
et al., 2008). 
 
NLRs are a growing family of regulatory proteins having a conserved 
tripartite domain structure: the C-terminal leucine-rich repeat (LRR) 
domain for recognizing ligands directly or indirectly, the NACHT 
domain and the N-terminal effector domain that generates 
downstream signaling. NLRs contain two major subfamilies called 
nucleotide-binding oligomerization domain (NOD) and 
NACHT/LRR/PYD-containing proteins (NAPLS). The larger subgroup of 
NLR proteins are the NALPs with 14 members identified in humans 
(Le Bourhis et al., 2007; Pétrilli et al., 2007). In general the NLR 
family is composed of 22 members in mammals (Martinon and 
Tschopp, 2005). 
NLRs are believed to remain in an inactive form until binding of a 
ligand, resulting in conformational changes, making downstream 
signaling possible. The activated NLR may then serve as a molecular 
platform for protein complexes such as inflammasomes (for NALPs) or 
nodosomes (for Nods) by triggering the activation of downstream 
effector molecules initiated via self-association and induced proximity 
of binding partners. The activation regulates intracellular signaling 
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pathways such as nuclear factor κB (NF-κB), caspase 1 
inflammasome and mitogen-activated protein kinases (MAPKs), which 
finally leads to altered gene expression of proteins, which play an 
essential role in inflammatory responses, cell fate or antimicrobial 
activity (Le Bourhis et al., 2007).  
For example, NOD1 specifically recognizes meso-diaminopimelic acid, 
a peptidoglycan product mainly present in gram-negative bacteria, 
whereas NALP3 and NOD2 sense muramyl dipeptide (MDP), a 
pepdidoglycan constituent, which can be found in gram-positive as 
well as in gram-negative bacteria (Abbas, 2010; Martinon et al., 
2005). 
 
 
 
Recognition of cytosolic DNA via cytoplasmic receptors 
 
The induction of type I IFN genes by Listeria monocytogenes requires 
the S/T protein kinase TBK1 and transcription factor interferon 
regulatory factor 3 (IRF3), but not TLRs or NOD proteins (Stockinger 
et al., 2004). Removal of DNA from Listeria extracts abolishes their 
ability to activate type I IFNs, suggesting that DNA is the ligand. On 
the one hand DNA may be released during Listeria infection as a 
consequence of LLO-mediated dirsruption of the vacuole (see chapter 
3.1.1) and on the other hand live Listeria may actively secrete DNA 
(Stetson and Medzhitov, 2006). 
 
Chemically synthesized dsDNA, like poly(dA-dT), triggers antiviral 
response through IFN-β promoter stimulator 1 (IPS-1) and 
TBK1/IKKε, including type I IFNs independently of TLRs and NLRs 
(Ishii et al., 2006). Whereas in case of Listeria infection IPS-1 is not 
needed for IFN-β induction (Soulat et al., 2006).  Recently it has 
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been shown that cytosolic poly(dA-dT) is converted into 5‘-ppp RNA 
by DNA-dependent RNA polymerase III to induce IFN-β via the RIG-I 
pathway, indicating RNA polymerase III as a DNA sensor that links 
DNA release by pathogenic bacteria and viruses in the host cell 
cytosol to IFN-β production and innate immunity (Chiu et al., 2009). 
 
LRRFIP1 was recently identified as cytoplasmic interferon-inducing 
sensor of nucleic acids in macrophages. This protein is able to detect 
dsRNA as well as dsDNA, which leads to activation of β-catenin and 
binding of IRF-3. Subsequently more p300 acetyltransferase is 
recruited to the IFN-β enhanceosome, leading to increased IFN-β 
induction. LRRFIP1 seems to play a crucial role in recognizing 
pathogens, like L.monocytogenes and vesicular stomatitis virus, 
resulting in innate immune responses, such as IFN-β expression 
(Yang et al., 2010).  
 
In 2007 a protein named DLM-1 or Z-DNA binding  protein 1 (ZBP1) 
was identified as cytoplasmic DNA sensor, termed DNA dependent 
activator of IFN-regulatory factors (DAI).  
In some cell types, but not in macrophages, DNA binding to DAI leads 
to type I IFN induction through the activation of IRF3 and, probably, 
IRF7. Notably, this receptor may itself recruit IRF3 and TBK1/IKKi in 
a DNA-dependent manner (Takaoka et al., 2007; Takaoka and 
Shinohara, 2008). 
 
AIM2 (absent in melanoma 2), a HIN-200 family member, also 
recognizes cytoplasmic dsDNA. AIM2 contains a carboxy-terminal 
oligonucleotide/oligosaccharide-binding domain and a pyrin domain at 
the N-terminus, which is important for interaction with ASC to 
activate an inflammosome. This further leads to the activation of 
caspase-1, a cystein protease that processes the inactive pro-IL1β 
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and proIL18 to their active proinflammatory cytokines IL1β and IL18, 
respectively. Additionally AIM2/ASC interaction leads to the formation 
of the ASC pyroptosome, which induces pyroptotic cell death in cells 
containing caspase1 (Burckstummer et al., 2009; Fernandes-Alnemri 
et al., 2009; Hornung et al., 2009; Roberts et al., 2009). 
 
 
 
Figure 3: Innate immune responses activated by cytosolic DNA. DAI, as well as an 
unknown receptor for cytosolic DNA trigger type I IFN expression via TBK1 activation. 
Polymerase III converts cytosolic DNA into 5’triphosphate dsRNA, which is sensed by 
RIG-I  (Hornung and Latz, 2010). 
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3.4 Signaling pathways triggerd by PRR stimulation 
 
 
3.4.1 TLR signaling 
 
Ligand binding to TLRs facilitates their dimerization and initiates 
downstream signaling pathways by using adaptor molecules such as 
Myeloid differentiation factor 88 (MyD88),  TIR-domain containing 
adapter protein (TIRAP or MAL),  TIR domain containing adapter 
protein inducing IFN-β (TRIF), and TRIF related adapter molecule 
(TRAM). All these proteins contain a Toll/interleukin 1 receptor (TIR) 
domain (Takeda and Akira, 2005). 
In general a MyD88 dependent and a MyD88 independent pathway 
can be distinguished. All TLRs use MyD88 except TLR3, which 
functions independently of MyD88.  TLR 4 can utilize both pathways 
(Dunne et al., 2005). 
 
 
MyD88 dependent signaling 
 
MyD88 has a C-terminal TIR domain and an N-terminal death domain 
and associates with the TIR domain of TLRs. The pathway will be 
further explained in the context of TLR4. After ligand binding to the 
TLR4, TIRAP recruits MyD88 to the receptor by binding to 
Phosphatidylinositol 4,5-bisphosphate (PIP2)  concentrated on the 
plasma membrane, interacting with MyD88 via their TIR domains, 
and thus promoting the interaction between TLR4 and MyD88 through 
TIR-TIR interactions. Then MyD88 recruits IL-1R associated kinase 4 
(IRAK-4) via the interaction of the death domains, present in both 
molecules. IRAK-4 mediates the phosphorylation of IRAK-1, making 
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the association with TNFR associated factor (TRAF6) possible. This 
interaction initiates two distinct signaling pathways.  
One pathway leads to the activation of activator protein 1 (AP-1) 
transcription factor, composed of c-Jun and c-Fos, through 
phosphorylation of Mitogen-activated protein kinase kinase 6 (MKK6) 
and 7, which in turn activate the p38 MAPK and c-Jun kinase (JNK) 
pathways, respectively and the other pathway activates the IKK 
complex (Dunne et al., 2005; Takeda et al., 2005). Once activated, 
the IKK complex induces phosphorylation, leading to ubiquitination 
and subsequent proteasomal degradation of the inhibitor IκB, that is 
then followed by release and nuclear translocation of NFκB (Schmid 
and Birbach, 2008). Both pathways make use of the Transforming 
growth factor β activated kinase 1 (TAK1)/TAK1 binding protein (TAB) 
complex (Thiefes et al., 2005). 
 
 
MyD88 independent signaling 
 
The Myd88-independent pathway is initiated by the recruitment of 
TRIF to the cytoplasmic TIR domain of TLRs (Lee et al., 2007). In 
case of TLR4, TRIF is recruited to the receptor on the plasma 
membrane through myristoylated TRAM, which is localized on the 
membrane and exclusively used in TLR4 signaling (Rowe et al., 2006). 
Via the interaction of TRIF with Receptor interacting protein 1 (RIP1), 
TRAF6 and TRAF3, downstream signaling pathways are activated.  
RIP1 plays a role in NF-κB activation but not in IRF3 activation. In 
certain cells TRAF6 may activate NF-κB and AP-1 through TAK1 
activation to induce the expression of inflammatory cytokine genes. 
TRAF3 is essential for IRF3 activation and subsequent IFN-β 
production. The interaction of TRAF3 with TRIF activates the 
redundant S/T kinases TBK1 and IKKi, which further phosphorylate 
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interferon regulatory factor 3 (IRF3). The activated IRF3 translocates 
into the nucleus and induces the expression of IFN-β and subsequent 
IFN-β inducible genes (Dunne et al., 2005; Lee et al., 2007; Takeda 
and Akira, 2007). 
 
 
 
 
Figure 4: TLR2, TLR3 and TLR4 signaling pathways (Takeuchi and Akira, 2010). 
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3.4.2 RIG-I/MDA5 signaling 
 
When ligand binding activates RIG-I or MDA5, an adaptor protein is 
recruited. This protein was simultaneously identified by four different 
groups and is therefore known as mitochondrial antiviral signaling 
(MAVS), IFN-β promoter stimulator 1 (IPS-1), virus induced signaling 
adapter (VISA) or CARD adapter inducing IFN-β (CARDIF) (Gack et 
al., 2010). This adaptor protein contains a CARD domain on the N-
Terminus, which is important for CARD-CARD interactions with the 
adaptor protein IPS-1. 
IPS-1 can directly interact with TRAF3, which activates TBK1/IKKi, 
leading to the sequential phosphorylation of IRF3 and subsequently to 
IFN-β induction. IPS-1 can also associate with TRAF6 and RIP1, 
inducing the expression of proinflammatory cytokine genes by 
activating the NFκB-pathway and the MAPK-pathway (Lee et al., 
2007). 
 
 
 
3.4.3 NLR signaling 
 
Upon ligand binding to NODs, the CARD-domain containing 
serine/threonine kinase RIP2, also known as RIPK2, Rip-like 
interacting caspase-like apoptosis-regulatory protein kinase (RICK), 
CARD-containing interleukin (IL)-1 beta converting enzyme (ICE) 
associated kinase (CARDIAK) and cholecystokinin (CCK), is recruited 
to the receptor via CARD-CARD interaction (Kobayashi et al., 2002). 
Oligomerization of NODs induces physical proximity of RIP2 proteins 
and the IKK subunits, leading to NF-κB activation. Also MAP kinases 
such as JNK, p38 and ERK can be activated (Lee et al., 2007; 
Martinon et al., 2005).  
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NALPs have the ability to recruit the adaptor Apoptosis-associated 
speck-like protein with CARD domain (ASC) through a homotypic 
PYD–PYD interaction, which in turn recruits caspase-1 via CARD–
CARD interaction, leading to the cross-activation of Caspase-1 which 
subsequently processes immature pro-IL-1β and pro-IL-18 into the 
mature forms IL-1β and IL-18. 
IL-1β and IL-18 bind to the IL-1 receptor (IL-1R) and IL-18 receptor 
(IL-18R) complexes, respectively. Similar to TLRs, these receptors 
have a cytoplasmic TIR domain that can recruit adaptors such as 
MyD88, which is responsible for activating NF-kB and other signaling 
cascades as mentioned in chapter 3.4.1 (Lee et al., 2007; Martinon et 
al., 2005). 
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3.5 Interferons 
 
Interferons (IFNs) are cytokines, which are produced in response to 
microbes and play an important role in the immune response. They 
can be differentiated into type I, type II and type III interferons. 
Classically, type I interferons have been identified as mediators of the 
early innate immune response to viral infections and type II 
interferons as antibacterial immunregulators (Decker et al., 2005). 
Type III interferons also induce a type I interferon like response 
(Zhou et al., 2007). 
 
There are several members of the type I IFN family, which share a 
structural homology and are encoded by genes in a single cluster on 
chromosome 9 (Abbas, 2010). This group includes IFN-α, which can 
be subdivided into 13 different subtypes, IFN-β, IFN-ε, IFN-κ, IFN-ω 
and additionally three others, which can be only found in pigs and 
mice. Type I IFNs interact with the type I IFN receptor, which consist 
of the IFNAR I and the IFNAR II chain (Decker et al., 2005). 
 
The only type II interferon is IFN-γ, which has already been 
mentioned in chapter 3.2. It is produced by T lymphocytes and NK 
cells and plays an important role in macrophage activation, where it 
induces a cell-autonomous microbial state against ingested 
intracellular pathogens. Type II IFNs are recognized by the type II 
IFN or IFN-γ receptor (IFNGR), which is built of the IFNGR I and 
IFNGR II chains (Abbas, 2010; Decker et al., 2005). 
 
The type III interferons comprise IFN-λ1 (IL-29), IFN-λ2 and IFN-λ3 
(IL-28A/B) in humans. Although they exhibit antiviral activity similar 
to type I interferons, they have evolved independently of type I 
interferons (Onoguchi et al., 2006). This group of interferons 
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interacts with cell surface receptors composed of interleukin-10 
receptor β and interleukin-28 receptor (Zhou et al., 2007). 
 
All IFN receptors regulate gene expression by activating the Janus 
kinase (JAK) – signal transducer and activator of transcription (STAT) 
pathway to induce several hundred IFN-stimulated genes (ISGs) that 
can be type-specific or common to two or all receptor types (Decker 
et al., 2005). 
 
IFN-α and IFN-β are the main type I IFNs that are synthesised during 
viral and bacterial infections. IFNs cause cells to produce enzymes 
that interfere with transcription of viral RNA or DNA and viral 
replication. They increase expression of class I major 
histocompatibility complex (MHC) molecules and the cytotoxic activity 
of NK cells. Type I IFNs promote the sequestration of lymphoctes in 
lymph nodes and in humans, type I IFNs also stimulate the 
development of TH1 cells (Abbas, 2010). In addition, the IFN-α/β 
system also modulates the oncogenic process and bone metabolism 
(Takaoka and Taniguchi, 2003). 
IFN-α and IFN-β are massively produced in most cell types in 
response to viral and bacterial infections. Type I IFNs are currently 
recognized as pivotal cytokines bridging innate and adaptive immune 
systems (Takaoka and Yanai, 2006). 
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3.6 The IFN-β enhanceosome 
 
Transcriptional enhancers are cis-regulated elements, which have an 
essential role in eukaryotic gene expression.  
Enhancers consist of multiple binding sites on the DNA, creating a 
combinatorial code, which directs transcription factors and 
polymerases to their specific promoter in response to stimulation.  
There is a wide range concerning length and complexity of enhancers. 
Binding of proteins on enhancers with binding sites tightly clustered 
in a short DNA fragment, leads to the formation of an  enhanceosome. 
 
The best characterized compact human enhanceosome forms on the 
virus inducible enhancer of the IFN-β gene. In 2007 the crystal 
structure of the transcription factors bound to the enhancer was 
described. 
It showed that assembly of a set of transcription factors, each of 
which can also bind, together with different partner proteins, to other 
enhancers, is necessary to fully activate the promoter. 
The IFN-β enhanceosome consists of the heterodimer ATF-2/c-Jun, 
IFR3 and IRF7, and NFκB (p50/RelA). These proteins bind to a 55bp 
stretch on the DNA. The IFN-β enhancer has been subdivided into 4 
positive regulatory domains (PRDs). The IRFs bind to PRDI and 
PRDIII, NFκB binds to PRDII and ATF-2/c-Jun bind to PRDIV. In case 
of virus infection, all these transcriptionfactors bind to their 
designated PRD and activate the transcription of the IFN-β gene. An 
IFN-β response should only occur, when the right set of transcription 
factors binds to the enhancer and only when all of them are present 
(Panne et al., 2007). 
 
 
 
  
Introduction   31 
 
 
 
Figure 5: The IFN-β enhanceosome. Transcriptionfactors bound to the IFN-β enhancer. 
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3.7 Interferons and the JAK/STAT pathway 
 
Type I and type II interferons can both activate the JAK/STAT 
signaling pathway.  
 
Type I interferons interact with the type I IFN receptor, composed of 
the IFNAR I and the IFNAR II chain, which are  permanently 
associated with the JAKs Tyrosine Kinase 2 (TYK2) or JAK1, 
respectively (Decker et al., 2002).  
JAKs have tandem kinase-homologous domains at the C-terminus. 
The first is a non-catalytic regulatory domain, whereas the second has 
tyrosine kinase activity (Rawlings et al., 2004). 
IFN binding to the receptor induces the tyrosine phosphorylation of 
cytokine-receptor cytoplasmic domains via JAKs, which then provides 
binding sites for the Src-homology-2 (SH2) domain of the STAT 
proteins (Levy and Darnell, 2002). 
The STAT proteins are then recruited to the JAKs, whereupon they 
are phosphorylated on a single tyrosine residue 701 (in case of 
STAT1) or 692 (in case of STAT2). For full Stat1 activity, an 
additional phosphorylation at serine 727 is necessary. Phosporylated 
STATs are able to interact through SH2 domain – phosphotyrosine 
interaction, which results in the formation of homo- or heterodimers, 
which further translocate to the nucleus, where they act as 
transcription factors.   
STAT1 homodimers bind to gamma IFN-activated site (GAS) 
elements, palindromic DNA recognition sites located in the promoter 
or enhancer region of IFN regulated genes. In case of STAT1/STAT2 
heterodimer formation, another protein, called IRF9 or p48, joins the 
complex. This transcription factor complex, termed ISGF3, binds to 
interferon stimulated response elements (ISRE) on the DNA and 
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activates the transcription of several type I IFN stimulated genes 
(ISGs) (Decker et al., 2002; Levy et al., 2002).  
 
Type II interferons (IFN-γ) bind to the IFNGR, consisting of IFNGR I 
and IFNGR II chains associated with JAK1 and JAK2. IFN-γ 
stimulation leads to the tyrosine phosphorylation of the receptor 
chains and subsequent recruiting, binding and phosphorylation of 
STAT1 on tyrosin 701. 
STAT1 homodimers are build up, tansclocate to the nucleus and bind 
to promoters containing GAS sites to regulate gene activation (Decker 
et al., 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6:  JAK-STAT pathway. Binding of interferons to their receptor activates JAKs, 
resulting in the phosphorylation of the receptor. Stat molecules are recruited to the 
phosphorylated receptor, are also phosphorylated and Stat1 homodimers or Stat1-
Stat2 heterodimers are formed.  The complexes translocate to the nucleus, bind to 
their respective site and activate gene transcription (Decker et al., 2005). 
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Interferon production is regulated via a positive feedback loop. 
Activation of TBK1 or IKKε leads to serine phosphorylation of IRF3, 
which triggers the induction of IFN-β and in some cells of IFN-α4. 
These ―early‖ IFNs lead to the formation of ISGF3 and one of its 
target genes Irf7. IRF7, which in turn is, like IRF3, also phosporylated 
by TBK1/IKKi induces the expression of a second stronger wave of 
IFNs (Decker et al., 2002, 2005). 
 
 
Figure 7: Activation of IRF3 and IRF7 and resulting type I IFN production. TLR4, or an 
unknown receptor in case of cytosolic bacteria, activate TBK1 or IKKε, which in terms 
phosphorylate IRF3. Phosphorylated IRF3 translocates to the nucleus and induces the 
transcription of IFN-β. IFN-β binds to its receptor, activates the Jak-Stat pathway, 
resulting in the induction of IRF7. IRF7 is again phosphorylated by TBK1 or IKKε, 
translocates to the nucleus and activates the transcription of a second wave of type I 
interferons (Decker et al., 2005).  
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3.7.1 STATs 
 
So far seven STAT proteins were identified, denoted STAT1, STAT2, 
STAT3, STAT4, STAT5a, STAT5b, and STAT6, in mammalian cells. 
These proteins consist of several conserved functional domains. The 
domain on the N-terminus is responsible for tetramerization of all 
STATs (with the probable exception of STAT2), and is also important 
for receptor recognition and phosphatase recruitment for some 
STATs. The N-domain is followed by a coiled-coil domain that 
participates in protein–protein interactions, a DNA binding domain, a 
linker domain implicated in DNA binding, an SH2 domain that 
mediates STAT dimerization and receptor binding, and a carboxy-
terminal transactivation domain (see Figure 8) (Meyer and 
Vinkemeier, 2004). 
 
For the translocation of STATs into the nucleus components of the 
Ran-dependent nuclear import machinery are used. Furthermore the 
karyopherin importin α5 plays an essential role (Levy et al., 2002; 
Meyer et al., 2004). For the nuclear export, the STAT molecules have 
to be in an unphosphorylated mode. For STAT1 and STAT3, there is 
evidence that TC45 (a nuclear tyrosine phosphatase) is a relevant 
STAT nuclear phosphatase (Levy et al., 2002).Unphosphorylated 
STATs can bind to the exportin CRM1 via leucine-rich nuclear export 
signals and move back to the cytoplasm (Meyer et al., 2004). 
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3.7.2 STAT1 F77A mutant 
 
The ~130 residues N-terminal domain of STAT1 plays an important 
role in many protein-protein interactions. Mutation of a single residue 
(Phe77 to Ala) located on the surface of the N-domain of STAT1 
precludes polymerization of STAT1 homodimers and 
dephosphorylation of tyrosin 701 (Meyer et al., 2004). 
The formation of STAT tetramers seems to be conserved throughout 
the STAT family and for some genes, especially those with multiple 
GAS in their promoters, the STAT tetramer binding seems to be 
important to fully activate gene expression. Activation of 
endogenouse STAT1 target genes is impaired in the STAT1 F77A 
mutant.   
Nuclear import is not affected in the STAT1 F77A mutant but due to 
the defect in dephosphorylation, persistent DNA binding and 
accumulation of STAT1 F77A molecules in the nucleus was observed 
(Meyer et al., 2004; Vinkemeier and Meyer, 2005; Zhong et al., 
2005).  
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Domain organisation of Stat1. The site of the F77A mutation and the tyrosin 
phosphorylation site are indicated.  
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4  Aims 
 
 
The main project of my diploma thesis was to replace the inlA gene of 
Listeria monocytogenes LO28 by the mutated version (S192N, 
Y369S) of EGDe inlA. This should enable oral infection experiments 
with a moderate dose of Listeria LO28.  
The mutated inlA (S192N, Y369S) can interact with the mouse E-
cadherin on intestinal epithelial cells. The exchange of the LO28 inlA 
by the EGDe inlA ensures that inlA is anchored in the cell wall of the 
bacterium and not secreted because of a nonsense mutation, which is 
present in the LO28 strain.   
 
Further I investigated the role of p38 MAPK, JNK, TBK1/IKKε or IKKβ 
on IFN-β induction and cell death in bone marrow derived 
macrophages (BMDMs). For this purpose we used pharmacological  
inhibition of the kinases.  
We wanted to clarify, if in case of Listeria monocytogenes LO28 
infection all transcription factors activated by these proteins are 
necessary for full IFN-β induction. Additionally, we examined cell 
death after inhibiton of the above-mentioned kinases.  
 
The third project investigated the Stat1 F77A mutant. We focused on 
the intracellular replication of L. monocytogenes LO28 in Stat1 F77A 
mutated BMDM. Additionally, we investigated the impact of the 
mutation on the induction of  IFN-β and IFN-induced genes as well as 
on  host cell death.  
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5 Results 
 
 
The modification of the inlA locus in Listeria monocytogenes LO28 is 
carried out in a two step process. The first step is to knock-out inlA in 
Listeria LO28 and the second step is the insertion of the mutated 
version of EGDe inlA in the Listeria LO28 inlA knock-out. For the 
insertion of inlA, five different strategies have been developed.  
  
5.1 Strategy for creating the inlA knock-out in L. 
monocytogenes 
 
The genome of Listeria monocytogenes LO28 has not been completely 
sequenced so far, therefore we had to sequence the gene locus and 
the flanking regions of inlA of Listeria LO28 (for primer sequences see 
materials).  
 
 
 
 
 
 
 
 
 
 
 
 
 LO28 gDNA  
SalI BglII 
a 
b‘ a‘ 
b 
downstream 
1017bp 
upstream 
1130bp 
SalI BglII 
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Figure 9: Overlap extension PCR. Flanking regions of L. monocytogenes LO28 inlA were 
amplified with specific primers and with an additional PCR the 2147bp product was 
generated from both fragments.    
 
 
The first step to create the inlA knock-out (k/o) was an overlap 
extension polymerase chain reaction (PCR) with a proof reading 
polymerase. As shown in figure 9, primer for the flanking regions of 
inlA of L. monocytogenes LO28 were designed.  
The outer primers (InlAdown_for, InlAup_rev) contain restriction 
enzyme sites for SalI or BglII, whereas the inner primers 
(InlAdown_rev, InlAup_for) have an attached sequence, which is 
complementary to the 5‘ end of the upstream fragment in case of a 
and to the 3‘ end of the downstream fragment in case of b.  
The downstream fragment (1017bp) and the upstream fragment 
(1130bp) were amplified and an additional PCR (using primer pair 
InlAdown_for and InlAup_rev) was accomplished for binding and 
amplification of the two DNA fragments, resulting in a 2147bp PCR 
product.  
This DNA fragment was ligated into the temperature sensitive shuttle 
vector pMAD, using the restriction enzymes SalI and BglII. The 
ligation was accomplished at 16°C over night.  
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Figure 10: Physical map of pMAD. Unique restriction enzyme sites in the multiple 
cloning site are indicated.  pclpB is a DNA fragment from S. aureus containing the clpB 
promoter region. bgaB is a DNA fragment containing the promoterless bgaB gene 
encoding a thermostable β-galactosidase. ermC is the gene for the erythromycin 
resistance in gram-positive bacteria. bla is the gene for β-lactamase, conferring 
resistance to β-lactam antibiotics. The ori pE194 is a temperature sensitive origin of 
replication for gram-positive bacteria, not working at temperatures above 37°C 
(Arnaud et al., 2004).  
 
 
The vector containing the insert was transformed into E.coli DH5α 
cells. Positive transformants were selected by growth on LB-ampicillin 
plates at 37°C. From overnight cultures of the grown colonies the 
plasmid was purified via Mini Prep, digested with the restriction 
enzymes SalI and BglII and loaded on a 1% agarose gel to check for 
the presence of the 2147bp insert. The insert was sequenced, using 
the primers seqInlALO28_1, seqInlALO28_2, seqInlALO28_3 and 
seqInlALO28_4, to ensure that there were no point mutations.  
 
The plasmid containing the correct insert was transformed into L. 
monocytogenes LO28 via electroporation. The integration of the 
plasmid into the genome took place at 42°C, the non-permissive 
temperature, which prevents the replication of the plasmid.  
10ml Brain-Heart-Infusion Medium (BHI) containing erythromycin 
were inoculated with the bacteria and grown at 42°C over night. On 
the next day 10ml fresh BHI with erythromycin were again inoculated 
with 100µl of the overnight (O/N) culture and incubated under the 
same conditions. This procedure was repeated for three days.   
On the third day 100µl of an appropriate dilution (1:1.000.000) were 
plated on BHI plates containing erythromycin and incubated at 42°C 
O/N.  
Several clones where selected and used to inoculate 10ml BHI with 
erythromycin for growth over night at 42°C. On the next day 
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bacterial glycerol stocks were prepared and stored at -80°C. From 
5ml of the rest of the O/N-cultures, genomic DNA from the Listeria 
was purified via Phenol/Chloroform extraction.  
 
Site directed integration of pMAD into the genome of Listeria 
monocytogenes LO28 requires homologous genomic sequences. 
Therefore the vector could either integrate via the downstream region 
or the upstream region of inlA.  The integration was analyzed via PCR 
with one primer (bgal) binding close to the multiple cloning site of 
pMAD and the other primer (EGD_for1) binding outside of the knock- 
out region. The length of the PCR product indicates if the plasmid 
integrated down- or upstream.  Both scenarios are shown in figure 
11. 
 
For the release of the plasmid, Listeria from the glycerol stock with 
the integrated plasmid were used to inoculate 10ml BHI and 
incubated without selection pressure at 28°C (the permissive 
temperature) for four days (passage of O/N culture as described for 
integration of the plasmid). 100µl of an appropriate dilution were 
plated on BHI plates containing no antibiotics. A colony-lift was 
performed to transfer clones to a BHI plate with erythromycin. 
Comparison with the original plate identified clones, which lost their 
antibiotic resistance, due to the homologous recombination event. 
Theoretically, two different types of reversion in either case of 
integration were possible. On the one hand excision of the vector 
could represent an exact reversion of the integration process, 
resulting in unchanged gDNA of L. monocytogenes LO28, on the other 
hand excision could result in the knock-out of InlA (Figure 11). 
After reversion of the plasmid the genomic DNA was analyzed by PCR 
(for primer sequences see materials). 
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Figure 11: Integration and reversion of pMAD. A. Homologous recombination of pMAD 
with insert and gDNA of L. monocytogenes LO28. B. Integration of pMAD via the 
upstream region. C. Integration of pMAD via the downstream region. D. Reversion of 
pMAD integration. The thinner lines indicate the reversion to the wildtype situation 
and the thicker lines indicate the reversion to the inlA knock-out.  
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5.2 Strategies for the insertion of EGD inlAmut 
 
 
5.2.1 Strategy 1 
 
Overview: The flanking regions of LO28 inlA and the mutated EGD 
inlA (S192N, Y369S) are amplified and and a fragment containing all 
three parts can be generated with an overlap extension PCR. This 
DNA fragment is cloned into pMAD and via homolgous recombination 
the EGD inlA is inserted into the LO28 inlA knock-out genome.  
 
The first step for the insertion of L. monocytogenes EGD inlA with the 
point mutations S192N and Y369S into the LO28 inlA knock-out are 
three different PCRs (Figure 12).  
One PCR to amplify the downstream region of InlA. Therefore the 
genomic LO28 DNA has to be used as template. The forward primer 
(InlAdownfor_Nco or down190_NcoI) includes an NcoI restriction 
enzyme site and the reverse primer (a, down_rev_lig) has an 
appendix (b‘) complementary to the 5‘ end of EGD inlA (b). 
The same has to be done for the upstream region with a forward 
primer (d, up_for_lig) containing a complementary sequence (c‘) to 
the 3‘ end of EGD InlA (c).  The reverse primer (InlAuprev_SalI or 
up224_SalI) includes a SalI restriction enzyme site for cloning into 
the shuttle vector pMAD.  
The third PCR amplifies the EGD inlA containing the point mutations 
S192N, Y369S. The plasmid pAUL-inlA2 with the above mentioned 
EGD inlA was kindly provided by Wolf-Dieter Schubert (Helmholtz 
Center for infection research Braunschweig).  To accomplish this PCR, 
primers (b, InlA_for_lig and d, InlA_rev_lig) with complementary 
regions to the 3‘ end of the downstream fragment (a‘) and to the 5‘ 
end to the upstream fragment (d‘) of LO28 inlA have to be used. 
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When the three fragments are amplified, they can be used for an 
additional overlap extension PCR to get one fragment with a length of 
4570 or 2837bp, depending on the length of the downstream and 
upstream fragment.  The primers for the overlap extension PCR have 
a restriction enzyme site for NcoI or SalI, respectively. 
When the whole fragment is amplified it has to be cloned into the 
temperature-sensitive shuttle vector pMAD via NcoI and SalI. For the 
rest of the procedure see chapter 5.1. Figure 13 shows the 
possibilities of integration and reversion of pMAD containing EGD inlA 
S192N, Y369S into the L. monocytogenes inlA knock-out genome. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12:  Overlap extension PCR to amplify the fragment needed for the insertion of 
the mutated EDG InlA into the L. monocytogenes LO28 inlA knock-out.   
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d‘ 
EGD InlA* 
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Figure 13: Integration and reversion of pAUL-inlA2 containing EGD inlA* (S192N, 
Y369S). A. inlA knock-out in LO28 gDNA. B. Integration of pAUL-inlA2 with EGD InlA* 
via the downstream region. C. Integration of pAUL-inlA2 with EGD inlA* via the 
upstream region. D. Reversion of pAUL-inlA2 indicated with thicker lines resulting in 
inserted EGD inlA* in the LO28 genome and with thinner lines resulting in the inlA 
knock-out situation. 
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5.2.2 Strategy 2 
 
Overview: The flanking regions of LO28 inlA and the 5’ and the 3’ end 
of the mutated EGD inlA are amplified.  With two overlap extension 
PCRs two fragments containing the downstream region and the 5’ end 
of inlA or the upstream region and the 3’ end of inlA can be 
generated. The fragments are Topo-cloned to get one large fragment, 
which is further cloned into pMAD. Via homolgous recombination the 
EGD inlA (S192N, Y369S) is inserted into the LO28 inlA knock-out 
genome.  
 
Four independent PCRs have to be accomplished. PCR1 and PCR2 
amplify the downstream and upstream region of LO28 inlA (see 
strategy 1). PCR3 and PCR4 amplify the 5‘ end and the 3‘ end of EGD 
inlA containing the point mutations. For PCR3 primer b (InlA_for_lig) 
with a complementary region to the 3‘ end of the downstream 
fragment (a‘) was used as forward primer. The reverse primer 
(InlA_AflII_rev) has an NcoI restriction enzyme site and binds to a 
region in EGD inlA containing an AflII restriction enzyme site.  
For PCR4 the complementary version without an NcoI restriction 
enzyme site of this primer has to be used as forward primer 
(InlA_AflII_for) and a primer with a complementary region to the 5‘ 
end of the upstream fragment (d‘) has to be used as reverse primer 
(InlA_rev_lig).  
Having the four fragments, two overlap extension PCRs can be 
accomplished. One to get the downstream region/InlA 5‘ fragment 
(#1) and another one to get the InlA 3‘/upstream region fragment 
(#2).  
Then fragment #1 has to be Topo-cloned into the vector pGEM and 
can be sequenced to ensure that there are no other point mutations, 
except S192N and Y369S. The vector containing the correct insert 
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and fragment #2 have to be digested with the restriction enzymes 
AflII and NcoI and fragment #2 can be cloned into pGEM and again 
sequenced.   
When the whole fragment, consisting of the downstream region of 
LO28 inlA, EGD inlA S192N and Y369S and the upstream region of 
LO28 inlA, is generated, pGEM and pMAD have to be digested with 
the restriction enzymes SalI and NcoI and the fragment can be cloned 
into pMAD.  
The rest of the procedure is described in chapter 5.1. Figure 14 shows 
the possibilities of integration and reversion of pMAD containing EGD 
inlA S192N, Y369S into the L. monocytogenes inlA knock-out genome. 
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Figure 14: Overlap extension PCR and pGEM/Topo cloning. Overlap extension PCR 
creating two PCR fragments (#1 and #2). Fragment #1 is Topo-cloned into the vector 
pGEM and then digested with AflII and NcoI restriction enzymes. The second fragment 
is additionally cloned into the vector resulting in the full length EGD inlA S192N, Y369S 
with the flanking downstream and upstream region.  After digestion with SalI and NcoI 
it can be cloned into pMAD and integrated into the Listeria LO28 genome.   
 
 
 
 
 
5.2.3 Strategy 3 
 
Overview: Two PCRs, amplifying the downstream region and the 5’ 
end of LO28 inlA or the upstream region and the 3’ end of LO28 inlA, 
are carried out. The two fragments are ligated, cloned into pMAD and 
a partial inlA knock-out is generated in the LO28 genome via 
homologous recombination. Through a second homologous 
recombination the mutated EGD inlA, located in the pAUL-InlA2 
vector, is inserted in the partial inlA k/o Listeria LO28 genome.  
  
PCR1 amplifies the downstream fragment and the 5‘ end of LO28. The 
forward primer (InlAdownfor_NcoI or down190NcoI) contains an NcoI 
restriction enzyme site and the reverse primer (InlA_2_rev), binding 
to LO28 inlA, contains a BamHI restriction enzyme site.  
PCR2 amplifies the 3‘ end of LO28 inlA and the upstream fragment. 
The primer (InlA_3_for) binding to LO28 inlA has a BamHI restriction 
enzyme site and the reverse primer (InlAuprev_SalI or up224_SalI), 
binding to the upstream fragment, contains a SalI restriction enzyme 
site. 
After digestion with NcoI/BamHI or BamHI/SalI the two fragments 
can be ligated resulting in a fragment containing only the 5‘ and the 
3‘ end of LO28 inlA and the flanking regions (Figure 15). 
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Figure 15: PCR and ligation. Forward and reverse primers, binding to LO28 inlA, 
contain a BamHI restriction enzyme site. The PCR fragments are digested and ligated. 
 
 
 
 
The PCR fragment can be cloned into the temperature-sensitive 
shuttle vector pMAD via NcoI and SalI. pMAD is transformed into L. 
monocytogenes LO28 and can integrate into the genome through 
homologous recombination. This event can take place via the 
downstream region/5‘ end of inlA or via the 3‘ end of inlA/upstream 
region. After reversion of the plasmid integration, the partial inlA 
knock-out is generated. The middle part of inlA containing the amino 
acids S192 and Y369 and the nonsense mutation, which is 
responsible for the truncated version of inlA are deleted(Figure 16).  
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Figure 16: Homologous recombination creating a partial inlA k/o in the Listeria LO28 
genome. Homologous recombination can take place via downstream/5’ region or via 
3’/upstream region. After reversion of pMAD the partial inlA k/o in the Listeria LO28 
genome is created.  
 
Listeria LO28 with the partial inlA k/o are used for a second 
transformation. pAUL-InlA2, containing the EGD inlA S192N, Y369S, 
is introduced and through homolgous recombination the plasmid can 
integrate into the Listeria LO28 genome. The homologous 
recombination can take place via the 5‘ or the 3‘ end of inlA. Both 
strategies are shown in figure 17. The same is true for the reversion 
of plasmid integration, which can result in the initial situation (partial 
inlA k/o) or in the insertion of EGD inlA S192N, Y369S in the LO28 
genome (Figure 17). 
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Figure 17: Integration and reversion of pAUL-inlA2 containing EGD inlA* (S192N, 
Y369S). A. Partial inlA knock-out in LO28 gDNA. B. Integration of pAUL-inlA2 with EGD 
inlA* via 5’ end. C. Integration of pAUL-inlA2 with EGD inlA* via 3’ end. D. Reversion of 
pAUL-inlA2 integration indicated with thicker lines resulting in inserted EGD inlA* in 
the LO28 genome and with thinner lines resulting in the partial inlA knock-out 
situation. 
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5.2.4 Strategy 4 
 
Overview: Two PCRs, amplifying the downstream region and the 5’ 
end of LO28 inlA or the upstream region and the 3’ end of LO28 inlA, 
are carried out. These two fragments are used for an overlap 
extension PCR, cloned into pMAD and a partial inlA knock-out is 
generated in the LO28 genome via homologous recombination. 
Through a second homologous recombination the mutated EGD inlA, 
located in the pAUL-InlA2 vector, is inserted in the partial inlA k/o 
Listeria LO28 genome.  
 
Strategy 4 is the same as strategy 3 except the initial step. Instead 
of primers containing a BamHI restriction enzyme site, primers with 
an appendix have to be designed.  Primer a (Start_lig_rev) has a 
complementary region to the beginning of the 3‘ end of inlA (b‘), 
whereas primer b (Stop_lig_for) has a complementary region to the 
end of the 5‘ end of inlA (a‘).With the amplified fragments, an overlap 
extension PCR can be accomplished, creating a partial inlA k/o, which 
consists of the downstream region, the 5‘ and the 3‘ end of LO28 inlA 
and the upstream region (Figure 18). For the rest of the procedure 
see strategy 3.   
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Figure 18: Overlap extension PCR to create the partial inlA knock-out, which can be 
used for the integration of EGD inlA S192N, Y369S via homologous recombination.  
 
 
 
5.2.5 Strategy 5 
 
Overview: The flanking regions of LO28 inlA and the mutated EGD 
inlA (S192N, Y369S) are amplified. The three fragments are ligated, 
cloned into pMAD and via homolgous recombination the EGD inlA is 
inserted into the LO28 inlA knock-out genome 
 
3 PCRs have to be accomplished. PCR1 amplifies the downstream 
region. The forward primer (InlAdownfor_NcoI or down190_NcoI) 
contains an NcoI restriction enzyme site and the reverse primer (a, 
down_rev) binds exactly before the start codon of LO28 inlA. PCR2 
amplifies the upstream region. The forward primer (d, up_for) binds 
directly after the stop codon of LO28 inlA and the reverse primer 
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(InlAuprev_SalI or up224_SalI) contains a SalI restriction enzyme 
site. 
PCR3 is for the amplification of EGD inlA S192N, Y369S (primer pair: 
InlA_for and InlA_rev). With these three fragments T4 ligations can 
be accomplished. There are several options of ligation but after NcoI 
and SalI digestion and agarose gel electrophoresis only the variant 
with the correct arrangement of the fragments also has the correct 
size (Figure 19). 
For the rest of the procedure see strategy 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: PCR and T4 ligation. The downstream and upstream fragment of LO28 inlA 
and the EGD inlA S192N, Y369S are amplified and used for T4 ligation. 
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5.3 InlA knock-out in L. monocytogenes LO28 
 
For analyzing the inlA knock-out in L. monocytogenes LO28, several 
PCRs were accomplished. Figure 20 shows the agarose 
gelelektrophoreses of the PCRs with primer pairs, where at least one 
primer binds to the LO28 locus if present. For the inlA k/o no band 
could be observed, using the primer pairs #1/#2, #5/#6 and #7/#8. 
The wildtype sample shows the bands with the correct size (see table 
1). The water control shows no DNA. In the scheme above the 
binding sites of the primers are indicated.  
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Figure 20: Control of inlA k/o. Agarose gel electrophoresis of PCRs for controlling the 
inlA k/o is shown. The scheme above shows the binding sites for the primer. The 
following primer pairs have been used #7/#8, #1/#2 and #5/#6. inlA-, internalin A 
knock-out; wt, wildtype.  
 
 
 
 
Figure 21 shows the primer pairs binding outside the inlA locus of 
Listeria LO28 and one primer pair binding to the shuttle vector pMAD, 
to anlayze the reversion of the plasmid. 
Using the primer pairs #3/#4 and #5/#6 results in a DNA fragment 
in the inlA k/o, as well as in the wildtype situation. The amplified 
fragments of the inlA k/o are 2403bp (length of LO28 InlA) smaller 
than the fragments of the wildtype. 
Primer pair #9/#10 binds to the vector pMAD, which has been used 
for the transformation of L. monocytogenes LO28. In the inlA k/o no 
DNA could be observed, asserting that the reversion of the plasmid 
has happened. The PCR conditions and the length of the PCR 
fragments are shown in table 1. 
For the water controls no DNA could be observed.    
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Figure 21: Control of inlA k/o. Agarose gel electrophoresis of PCRs for controlling the 
inlA k/o are shown. The scheme above shows the binding sites for the primer. The 
following primer pairs have been used #3/#4, #5/#8 and #9/#10. inlA-, internalin A 
knock-out; wt, wildtype.  
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Oligos 
 
gene Ta (°C) 
extension 
time  (sec) 
LO28 
wt 
LO28 
ΔinlA 
pMAD 
 
#1/#2 
 
InlA 57 30 326 - - 
 
#3/#4 
 
InlA 54 120 2736 337 - 
 
#5/#6 
 
down 54 120 2043 - - 
 
#7/#8 
 
up 54 60 1880 - - 
 
#9/#10 
 
pMAD 57 60 - - 630 
 
#5/#8 
 
locus 54 330 5457 3053 - 
 
Table 1: Primerpairs with binding sites, annealing temperature (Ta), extension time 
and length of PCR fragment are listed.  
 
 
 
5.4 Insertion of EGDe inlA into L. monocytogenes 
LO28 
 
The insertion of the Listeria monocytogenes EGD inlA S192N, Y369S 
could not be accomplished so far. 
Strategy 3, 4 and 5 failed, for strategy 1 and 2 the initial PCRs were 
done.   
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5.5 The role of TBK, p38 MAPK, IKKβ and JNK in 
IFN-β induction and death of macrophages upon 
infection with Listeria monocytogenes 
 
The effect of pharmacological inhibition of TBK1/IKK , p38 MAPK, 
IKKβ and JNK on IFN-β induction was analyzed by real-time PCR. 
Bone marrow–derived macrophages (BMDM) were treated with the 
respective inhibitors 1 hour before infection and during the infection. 
The cells were infected with L. monocytogenes LO28 with a 
multiplicity of infection (MOI) of 10 and cell extracts were taken 4, 6 
and 8 hours after infection.  
After TBK1/IKKε inhibition no IFN-β could be observed. When using 
the p38 inhibitor we monitored an about 4-fold decrease of IFN-β 
induction at the 4h timepoint (see Figure 22), but looking at later 
timepoints (see Figure 24), the IFN-β induction increased and 
reached a higher level than non-treated BMDM at 8 hours.  
The IKKβ inhibitor slightly decreased IFN-β induction and after JNK 
inhibiton the IFN-β induction was strongly decreased, comparable to 
TBK1/IKKε inhibition (see Figure 22).  
Combination of two of the inhibitors always resulted in the reduction 
of IFN-β to the level achieved by the inhibitor with the stronger effect 
(see Figure 23). This leads us to the conclusion that combination of 
inhibitors do not show a syngergistic effect.  
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Figure 22: Relative IFN-β induction by infection of BMDM with Listeria monocytogenes 
LO28 following treatment with TBK1/IKKε inhibitor, p38 MAPK inhibitor, IKKβ inhibitor 
and JNK inhibitor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Relative IFN-β induction by infection of BMDM with Listeria monocytogenes 
LO28 following treatment with p38 MAPK+IKKβ inhibitor, p38 MAPK+JNK inhibitor and 
IKKβ+JNK inhibitor. 
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Figure 24: Relative IFN-β induction by infection of BMDM with Listeria monocytogenes 
LO28 following treatment with p38 MAPK inhibitor. 
 
 
 
The cell viability of BMDM, treated with inhibitors 1 hour before and 
during infection, was evaluated by Flow Cytometry. The cells were 
infected with L. monocytogenes LO28 and after 24 hours the cells 
were stained with propidium iodide (PI), a fluorescent molecule able 
to intercalate into the DNA of dead cells.  
Figure 25 shows the percent of cell death after the different 
treatments and Listeria LO28 infection for 24 hours. It can be seen 
that after TBK1/IKKε inhibition the rate of dead cells is slightly 
increased. After p38 MAPK and JNK inhibition cell death is reduced by 
half compared to control cells. 
The IKKβ inhibitor could not be used for this experiment because 
after incubation longer than 10 hours all BMDM died, when the 
inhibitor was used in the recommended concentration of 6µM. 
Sublethal concentrations of 1,3-1,5µM failed to block IκBα 
degradation (see Figure 26). 
 
  
Results   63 
 
 
 
 
 
Figure 25: Cell death analysis of L. monocytogenes LO28-infected BMDM after 
treatment with TBK1/IKKε inhibitor, p38 MAPK inhibitor and JNK inhibitor. PI staining 
was performed 24h after infection.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: Western blot analysis. The IKKβ inhibitor was used at the recommended 
concentration of 6µM and at lower concentrations of 1,5µM and 1,3µM in Listeria 
infected BMDM. IκBα degradation could be observed at the lower concentrations of 
the inhibitor. The protein extracts were taken 45min after infection and ERK was used 
as loading control. 
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To ascertain that the slightly increased cell death after TBK1/IKKε 
inhibition and Listeria LO28 infection did not result from residual 
endogenous IFN-β and type I IFN signaling, we determined the 
tyrosin phosphorylation of Stat1.  TBK1/IKKε inhibition completely 
abrogated Stat1 tyrosine phosphorylation following Listeria LO28 
infection, indicating that there is no residual IFN-β induction (see 
Figure 27). 
 
 
 
 
 
Figure 27: Western Blot analysis. Stat1 tyrosine phosphorylation after TBK1/IKKε 
inhibitor treatment and Listeria LO28 infection was examined. The cell extracts were 
taken 2h and 4h after infection and ERK was used as loading control.   
 
 
 
 
The TBK1/IKKε inhibitor was shown to block p38 MAPK activation 
(Clark et al., 2009). To examine the role of TBK1 without affecting 
other pathways, knock-down experiments were performed. Compared 
to wildtype controls, TBK1 siRNA transfected into BMDM did not cause 
a difference in cell death after L. monocytogenes LO28 infection for 
24 hours. The macrophages were infected with an MOI of 30 (Figure 
28).  
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Figure 28: Cell death analysis of L. monocytogenes LO28 infected BMDM after TBK1 
siRNA knock-down. PI staining was performed 24h after infection.  The TBK1 knock-
down efficiency was controlled by western blot analysis. ERK was used as loading 
control. NT siRNA, non target siRNA. 
 
 
 
To obtain further genetic confirmation of the results with inhibitors, 
IKKβ deficient (IKKβ-/-) BMDM were used to investigate the viability 
of macrophages after Listeria LO28 infection. The spontaneous cell 
death was reduced to more than a half in IKKβ-/- BMDM, compared 
to wildtype cells, whereas the cell death rate after infection for 24h 
was only slightly decreased (see Figure 29).  
 
 
 
Figure 29: Cell death of L. monocytogenes LO28 infected IKKβ-/- and wildtype BMDM. 
PI staining was performed 24h after infection.   
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We also determined the induction of the IFN-β gene in IKKβ-/- 
macrophages. A difference to wt macrophages was observed at the 
later timepoint. 6 hours after Listeria infection, with an MOI of 10, the 
IFN-β induction in IKKβ-/- cells was slightly decreased (see Figure 
30). 
 
 
 
 
 
Figure 30: Relative IFN-β induction of wt and IKKβ-/- BMDM after Listeria 
monocytogenes LO28 infection. 
 
 
 
 
To explain the different results obtained with the IKKβ inhibitor and 
the IKKβ-/- macrophages we examined whether the IKKβ inhibitor 
influences the phosphorylation of p38 MAPK, AKT, JNK and the tyrosin 
phosphorylation of Stat1. Western blot analysis revealed that the 
IKKβ inhibitor has no inhibitory function on either of these kinases. 
However, the tyrosin phosphorylation of Stat1 was decreased 
compared to the non treated LO28-infected cells, which could be due 
to the decreased IFN-β induction after IKKβ inhibitor treatment 
(Figure 31). 
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Figure 31: Western blot analysis. The influence of the IKKβ inhibitor on the 
phosphorylation of Stat1 at tyrosine 701, or the phosphorylation of p38 MAPK, JNK or 
AKT was investigated. The unphosphorylated proteins are shown as loading controls. 
 
 
 
Since Listeria DNA was suggested to stimulate IFN-β gene 
transcription we investigated the IFN-β induction in RAW 264.7 
macrophages and in BMDM after inhibitor treatment and poly(dA-dT) 
transfection. The cells were treated with the inhibitors 1 hour before 
and during the transfection and the cell extracts were taken 2 and 4 
hours after transfection.  
The effect of the inhibitors after poly(dA-dT) transfection in RAW 
264.7 macrophages was comparable to the effect after Listeria LO28 
infection in BMDM, with the exception of p38 MAPK inhibition 
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(compare Figure 22 and 32). 4 hours after poly(dA-dT) transfection, 
IFN-β induction was completely reduced. 
Treatment with the TBK1/IKKε inhibitor and the JNK inhibitor showed 
a strong decrease in the IFN-β induction. At the 4 hour timepoint the 
p38 MAPK inhibitor had the strongest effect (see Figure 32).  
Using two inhibitors in combination always showed a strong decrease 
in IFN-β induction in RAW 264.7 cells (see Figure 33).  
 
 
 
 
 
Figure 32: Relative IFN-β induction in RAW 264.7 macrophages after inhibitor 
treatment and poly(dA-dT) transfection. A TBK1/IKKε inhibitor, a p38 MAPK inhibitor, 
an IKKβ inhibitor and a JNK inhibitor were used. Cell extracts were taken 2 and 4 hours 
after transfection.  
 
 
  
Results   69 
 
 
 
 
 
Figure 33: Relative IFN-β induction in RAW 264.7 macrophages after inhibitor 
treatment and poly(dA-dT) transfection. The inhibitors were used in combinations. Cell 
extracts were taken 2 and 4 hours after transfection.  
 
 
 
In poly(dA-dT) transfected BMDM only the TBK1/IKKε inhibitor 
decreased IFN-β induction by about 50% . The p38 inhibitor and the 
IKKβ inhibitor had no effect on the IFN-β induction. Treatment with 
the JNK inhibitor resulted in an increase of IFN-β induction after 
poly(dA-dT) transfection, which is stronger at the 2 hour timepoint 
compared to the 4 hour timepoint (see Figure 34). 
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Figure 34: Relative IFN-β induction in BMDM after inhibitor treatment and poly(dA-dT) 
transfection. A TBK1/IKKε inhibitor, a p38 MAPK inhibitor, an IKKβ inhibitor and a JNK 
inhibitor were used. Cell extracts were taken 2 and 4 hours after transfection.  
 
 
 
Overview of inhibitors and their effects  
 
 
inhibitor  kinase Inhibition of IFN-β induction  
Inhibition of 
cell death  
  
BMDM 
LO28  
BMDM 
poly(dA/dT)  
RAW 264.7  
poly(dA/dT)  
BMDM 
LO28  
BX795  TBK1/IKKε  +++  ++  ++  -  
SB203580  p38 MAPK  ++  +  +++  +  
BIX02550  IKKβ  +  no effect  +  toxic  
SP600125  JNK  +++  -  ++  +  
 
Table 2: Overview of inhibitors and their effect on IFN-β induction and cell death. LO28, 
infection with L. monocytogenes LO28; poly(dA-dT), transfection with poly(dA-dT); +++, 
completely inhibited; ++, strongly inhibited; +, slightly inhibited; -, enhanced 
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5.6 Intracellular Listeria growth and gene 
expression in Stat1 F77A macrophages  
 
 
We investigated the intracellular growth of Listeria monocytogenes 
LO28 in wildtype and Stat1 F77A BMDM. To this end colony forming 
unit assays were performed.  The cells were infected at an MOI of 7,5 
and samples were taken at the indicated timepoints. For each 
genotype we also included samples, which were after pretreatment 
with IFN-γ (5ng/µl) for about 12 hours. IFN-γ remained present in 
the medium for the whole experiment.Comparing the two genotypes, 
we observed that the reduced growth of Listeria caused by IFN-γ 
treatment of wt BMDM was not observed in the Stat1 F77A BMDM. 
(see Figure 35).  
 
 
 
Figure 35: CFU assay. CFU of Listeria monocytogenes LO28 per well at the stated 
timepoints with- or without IFN-γ pretreatment.. 
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We further investigated the expression of four different genes after 
Listeria LO28 infection or IFN-γ treatment in Stat1 F77A BMDM. The 
cells were infected at an MOI of 10 and cell extracts were taken 2, 4, 
6 and 8 hours after infection. IRF1, Gbp2 and Tap1 induction was 
strongly reduced in Stat1 F77A BMDM compared to wildtype 
macrophages in either infected or IFN-γ treated cells (see Figure 36, 
37). 
The Mx2 expression was only analyzed after Listeria LO28 infection. 
Stat1 F77A BMDM showed a decreased induction of Mx2, especially 4 
and 6 hours after infection (see Figure 36).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36: Gene induction after L. monocytogenes LO28 infection. Expression of IRF1, 
Gbp2, Tap1 and Mx2 genes is shown for wildtype and Stat1 F77A BMDM.  
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Figure 37: Gene induction after IFN-γ treatment. Expression of IRF1, Gbp2 and Tap1 
genes is shown for wildtype and Stat1 F77A BMDM.  
 
 
 
 
For cell death analysis, PI staining was performed. The cells were 
infected at an MOI of 30 and stained after 24 hours. We could not 
observe any significant difference in Stat1 F77A BMDM compared to 
wildtype cells (see Figure 38). 
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Figure 38: Cell death of L. monocytogenes LO28-infected wildtype and Stat1 F77A 
BMDM. PI staining was performed 24h after infection.   
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6 Discussion 
 
 
Listeria monocytogenes, a gram-positive food-borne pathogen, 
causes severe diseases with high mortility rates in 
immunocompromised humans and infections of the fetus in pregnant 
women (Sleator et al., 2009).  Therefore it is important to study the 
immune responses, caused by this microbe. The model organism 
used for infections with Listeria is the mouse. Due to the failure in the 
interaction of InternalinA, the protein important for the 
gastrointestinal uptake of Listeria, and its receptor E-cadherin in 
mice, it is difficult to investigate oral infections with moderate doses 
of the pathogen. 
There are two strategies to avoid this problem. On the one hand  a 
humanized mouse line was generated and on the other hand a 
murinized pathogen was engineered (Sleator et al., 2009; Wollert et 
al., 2007).  
 
Our lab is mainly interested in the innate immune response to Listeria 
monocytogenes. Compared to other strains Listeria LO28 causes 
robust induction of the type I IFN genes (Reutterer et al., 2008). 
Therefore this strain is used for our experiments.  The aim was to 
create murinized Listeria LO28, where two amino acids of InlA are 
substituted, making a productive interaction between the InlA and 
the E-cadherin of mice possible. Furthermore we aimed at exchanging 
the LO28 InlA with the EGDe version, which has a cell wall anchor 
motif in contrast to LO28 (Jonquières et al., 1998).    
 
The InlA of Listeria monocytogenes LO28 could be knocked out via 
homologous recombination. The insertion of the mutated EGDe InlA 
was not successful so far. 
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We have developed five different strategies, but three of them failed. 
Strategy 3 and 5, as described in the results, failed due to the output 
of DNA after T4 ligation. Concerning strategy 4, the overlap extension 
PCR did not work, which could probably be resolved by using another, 
more potent proof-reading polymerase.  
Recently, the overlap extension PCR of strategy 1 and strategy 2 was 
carried out succesfully, therefore the next step of cloning the 
fragment into the temperature-sensitive shuttle vector and the 
sequencing of the amplified PCR fragment can be performed.   
The insertion of the mutated EGDe inlA into the inlA knock-out 
Listeria will progress further and numerous applications of the 
recombinant stains are on our list of future experiments. 
 
Type I IFN plays a major role in the innate immune response to 
Listeria monocytogenes. Earlier studies revealed the structure of the 
virus-induced IFN-β enhancer, showing the assembly of several 
transcription factors on the DNA. The IFN-β enhanceosome is built of 
ATF-2/c-Jun, IRF3/IRF7 and NFκB (Panne et al., 2007). We wanted to 
investigate, L. monocytogenes LO28 infection employs all of these 
transcription factors to fully induce IFN-β in BMDM.  
Using inhibitors against kinases, which are involved in the signaling 
after Listeria infection allowed us to suppress the activation of the 
above mentioned transcription factors. Our data show that TBK1/IKKε 
and JNK, leading to the activation of IRF3/IRF7 or c-Jun, respectively, 
are essential for IFN-β induction. Inhibition of these proteins resulted 
in total loss of IFN-β mRNA.  
Inhibition of the p38 MAPK or IKKβ, playing a role in phosphorylation 
of ATF-2 or NFκB, respectively, did not show these dramatic effects. 
In case of IKKβ, the IFN-β induction after Listeria infection was only 
reduced by about 50 percent.  
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Additionally we examined the IFN-β induction of IKKβ-/- BMDM after 
Listeria infection. There was no difference in IFN-β induction 
compared to wildtype cells, except for the 6 hour timpoint, where a 
slight decrease in IFN-β induction was noted in IKKβ-/- cells. 
The strongest effect on IFN-β induction after Listeria infection of 
IKKβ-/- BMDM, or in IKKβ inhibitor treated cells was always observed 
at the latest analysed timepoint. 
Interestingly, the p38 MAPK inhibitor delayed IFN-β induction. For the 
early timepoints IFN-β is reduced by approximately 70%, but IFN-β 
induction after 8 hours of Listeria infection increased to more than 
200% compared to the non treated macrophages.  
To define the maximum of the IFN-β induction after p38 MAPK 
inhibition, experiments with later time points would be useful. 
Our findings reveal that all transcription factors (c-Jun, ATF-2, IRF3, 
IRF7 and NFκB) are necessary for full IFN-β induction after L. 
monocytogenes LO28 infection, but that compared to IRF3/7 and 
ATF2 NFkB appears to be of minor importance. 
Although IKKα does not seem to be critical for cytokine induced IκB 
degradation and subsequent NFκB activation, it functions in the 
nucleus to activate the expression of NFκB responsive genes through 
phosphorylation and subsequent acetylation of specific residues in 
histone H3 (Anest et al., 2003; Yamamoto et al., 2003). This activity 
may explain the difference between treating macrophages with an 
IKK inhibitor and the use of IKKb-/- macrophages. 
 
To compare Listeria infection with the effects of its proposed PAMP for 
IFN-β stimulation, we transfected inhibitor treated RAW 264.7 
macrophages and BMDM with poly(dA-dT), activating signaling 
exclusively via intracellular receptors. The cytosolic receptor for L. 
monocytogenes, which leads to IFN-β gene transcription has not been 
identified, but it is without controversy that IFN-β is induced via TBK1 
  
 
 78    Discussion 
 
 
and IRF3 (Perry et al., 2004; Stockinger et al., 2004). Concerning 
poly(dA-dT), it is possible that the DNA dependent RNA polymeraseIII 
converts poly(dA-dT) into 5‘-ppp RNA leading to IFN-β induction via 
RIG-I (Chiu et al., 2009).   
 
After inhibitor treatment and poly(dA-dT) transfection in RAW 264.7 
macrophages, we saw that the TBK1/IKKε, p38 MAPK and the JNK 
inhibitor had a stronger effect compared to the IKKβ inhibitor treated 
cells, which is in agreement with our results after Listeria infection. 
Regarding the inhibitor treated, poly(dA-dT) transfected BMDM, the 
IFN-β induction was only reduced after TBK1/IKKε inhibitor treatment 
and after p38 MAPK inhibition at early timepoints. The IKKβ inhibitor 
had no effect on the IFN-β gene expression and the JNK inhibitor 
enhanced IFN-β induction. We do not have an explanation for the 
increased IFN-β induction after JNK inhibition, but the generally very 
weak effects could be due to a poor transfection rate. To draw any 
conclusions of the poly(dA-dT) transfection in BMDM, further 
investigations would be necessary, but in case of inhibitor treated, 
poly(dA-dT) transfected RAW 264.7 macrophages, the results are in 
line with the data of the inhibitor treated, Listeria infected BMDM.   
 
To this date there are no published data about the IKKβ inhibitor, 
BIX02550 (kindly provided by Boehringer-Ingelheim) and its side 
effects. Therefore we investigated the effect of the inhibitor on the 
phosphorylation of several proteins, including p38 MAPK, JNK, AKT 
and Stat1. We could not observe an inhibition of the phosphorylation 
of any of these proteins, except for Stat1, where the phosphorylation 
was slightly decreased, which could be due to the reduced IFN-β 
induction after IKKβ inhibition.   
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We also investigated the cell death of L. monocytogenes LO28- 
infected BMDM after inhibitor treatment. NFκB and p38 MAPK play an 
important role in maintaining cell survival in macrophages. Published 
data showed that inhibition of one of these proteins leads to 
compromised survival of macrophages (Park et al., 2005).  
Furthermore, a correlation between IFN-β induction and cell death 
after L. monocytogenes infection in macrophages has been 
demonstrated (Stockinger et al., 2002).  
Surprisingly, we observed that after TBK1/IKKε inhibition, the 
percentage of dead macrophages after Listeria LO28 infection is 
slightly increased. We would have expected a higher viability of 
Listeria infected macrophages after TBK1/IKKε inhibition, due to the 
fact that IFN-β induction is recduced to a minimum.  
In recent publications (Clark et al., 2009), a number of side effects 
elicited by the TBK1/IKKε inhibitor were investigated. To be able to 
study the contribution of TBK1 on the cell death of macrophages, we 
generated an siRNA knock-down of TBK1 in BMDM. This did not result 
in a significant effect on macrophage death, suggesting that the 
slightly increased cell death caused by the TBK1/IKKε inhibitor may 
be due to side effects of the chemical component (Clark et al., 2009).  
Inhibition of p38 MAPK, reduced cell death of Listeria infected BMDM 
after 24 hours. This is in contrast to recently published data, 
suggesting that the p38 MAPK and IKKα/β, synergize to induce 
transcription of two major anti-apoptotic genes, Bfl-1/AI and Pai-2 
(Park et al., 2005).  Our results would suggest that in case of Listeria 
infected macrophages p38 MAPK has a proapoptotic effect.  
Cell survival assays in presence of the IKKβ inhibitor could not be 
performed, due to the fact that all macrophages, either infected or 
not, died within 12 hours. 
Using the inhibitor in a lower concentration led to the survival of the 
cells, but drastically reduced the inhibitory function. Therefore we 
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used IKKβ-/- BMDM to investigate the cell death after L. 
monocytogenes infection. In infected IKKβ-/- macrophages, slightly 
more cells survived.  
Cell death in uninfected IKKβ-/- cells was reduced compared to 
wildtype cells. Earlier studies showed that IKKβ-/- mice have a severe 
defect in NFκB activation (Li et al., 1999). This would suggest that 
NFκB plays a role in the activation of pro-apoptotic genes. To confirm 
these data, the experiment would need to be repeated. Due to the 
lack of cells, it was performed only once. 
JNK is known to have a dual role in both apoptotic and anti-apoptotic 
signaling pathways, indicating that the function of JNK is complex 
(Lamb et al., 2003). In our experiments Listeria LO28 infection and 
treatment with a JNK inhibitor resulted in increased survival of 
macrophages compared to non-treated cells, leading us to the 
conclusion that in our approach the JNK pathway has a pro-apoptotic 
role.                                                                                                                                                                                                                               
 
Interferons lead to the activation of JAK-STAT signaling. Depending 
on the type of IFN Stat homo- or heterodimers are formed via 
phosphotyrosin-SH2 domain interaction (Decker et al., 2005). The 
activation of some genes also depends on the oligomerisation of Stat 
proteins, where the N-Terminus plays a crucial role. The Stat1 F77A 
mutant fails to form Stat1 tetramers, due to the mutation in the N-
terminal region (Meyer et al., 2004; Vinkemeier et al., 2005).  
In our studies we adredded the question wether this mutation 
influences the intracellular replication of L. monocytogenes LO28 in 
BMDM. Our results showed that the replication of Listeria in IFN-γ-
treated Stat1 F77A BMDM is stronger compared to the replication in 
IFN-γ-treated wildtype BMDM up to 9 hours of infection. This shows 
that the mutation decreases the ability of IFN-γ to activate 
macrophages.  
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Consistent with this the induction of IFN-responsive genes by Listeria 
LO28 infection or after treatment with IFN-γ was strongly reduced in 
Stat1 F77A BMDM. In both cases we could see a strong decrease in 
IRF1, Gbp2 and Tap1 expression. IRF1 contains a single GAS but no 
ISRE in its promoter (Kimura et al., 1996). Our results thus indicate 
that Stat interactions, crucially involving the Stat1 N domain, are 
mandatory for full transcriptional activity of promoters containing 
only one GAS site. Published data showed that the ability to form Stat 
tetramers on DNA did not require multiple GAS sites (Meyer et al., 
2004). Gbp2 and Tap1 have ISRE in their promoters in addition to 
GAS DNA (Min et al., 1998; Ramsauer et al., 2007). Because of the 
decreased induction of these genes, we wanted to determine, if the 
expression of Mx2, which is an ISRE driven gene (Asano et al., 2003), 
is also influenced by Stat1 F77A macrophages.  
We observed that the induction of this gene was also significantly 
reduced 2 and 4 hours after infection with Listeria LO28. 
RT-PCR analysis of IFN-α dependent target genes (ISG-15 and ISG-
56k), demonstrated reduced transcriptional activity in Stat1 F77A 
expressing U3A cells (Meyer et al., 2004). 
This leads us to the conclusion that there is not only a defect in Stat1 
oligomerization, but that the mutation also influences the formation 
of ISGF3. An alternative explanation could be that the N-terminal 
domain also plays a role in the recruitment of transcriptional co-
activators or the recruitment of interacting transcription factors.  
In vitro studies showed that a defect in interaction of Stat dimers 
with the promoter DNA can be excluded (Meyer et al., 2004).  
 
Investigation of the cell death of Stat1 F77A macrophages after 
infection with L. monocytogenes did not show any differences to 
wildtype cells, indicating that the mutation does not influence the 
expression of any pro-apoptotic or pro-survival genes.
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7 Materials  
 
 
7.1 Bacteria 
 
Listeria monocytogenes LO28 wildtype (LO28 wt) 
The strain was kindly provided by Pascale Cossart (Institute Pasteur, 
Paris). 
 
 
7.2 Cells 
 
All cells were routinely grown at 37°C, 5% CO2 and a humidity of 
95%.  
 
RAW 264.7 Macrophages 
This cell line was cultured in DMEM containing 10% of FCS.  
 
Primary Macrophages 
Bone marrow derived macrophages were generated from wildtype 
mice or from a knock-in variant carrying the mutation F77A in the 
Stat1 gene with the genetic background of C57Bl/6. 
The Stat1 F77A bone marrow samples were provided by Uwe 
Vinkemeier (Queen‘s Medical Centre, University of Nottingham). 
The mice were housed under special, pathogen free conditions. 
The cells were grown at 37°C, 5%CO2 and 95% humidity and used 
after 10-14 days of cultivation. 
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7.3 Common reagents and solutions 
 
Media 
 
LB 
10g Trypton 
5g yeast extract 
10g NaCl 
fill up to 1 liter with H2O and adjust ph to 8 
 
BHI 
37g BHI 
fill up to 1 liter with H2O 
 
 
Solutions and antibiotics used in cell culture 
 
10x PBS (phosphate-buffered saline) 
1,4M NaCl 
25mM KCl 
81mM Na2HPO4 x 2H2O 
15mM KH2PO4 
pH 7,4 
 
1000x Penicillin/Streptomycin 
0,6g Penicillin 
1g Streptomycin 
add H2O to 10ml 
filter sterilize and store at -20°C 
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Gentamycin 
Gentamycin was diluted in water to a stock concentration of 50mg/ml 
and stored at 4°C. 
 
 
PCR reagents 
 
10mM dNTP mix 
10mM dATP 
10mM dCTP 
10mM dGTP 
10mM dTTP 
 
RNAse/DNAse free water was purchased from Sigma 
 
TAE 
242g Tris base 
57,1ml acetic acid 
100ml 0,5M EDTA 
pH 8 
 
DNA loading dye 
10mM Tris pH 7,6 
60% Glycerol 
60mM EDTA 
0,15% OrangeG 
0,03% Xylene Cyanol 
fill up with H2O to the desired volume 
 
 
 
  
Materials   85 
 
 
25x RNA running buffer: 
0,25M Na2HPO4 
0,25M NaH2PO4 
 
RNA loading dye 
80% (v/v) Formamid 
1mM EDTA 
add bromphenolblue until desired color is reached 
 
10.000x EtBr 
5mg ethidium bromide/ml H2O 
 
 
Solutions for protein isolation 
 
Frackelton buffer 
10mM Tris 
50mM NaCl 
30mM NaPPi 
50mM NaF 
1% Triton X-100 
pH: 7-7,5 
store at 4°C 
 
1M DTT 
Dithiothreitol 
0,01M sodium acetate (pH 5,2) 
 
100mM PMSF 
100mM Penylmethylsulfonylfuoride in 2-Propanol 
store at 4°C 
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10mM sodium vanadate 
18mg Na3O4V 
10μl HCl:H2O in the ratio 1:1 
add H2O to 20ml 
Boil the solution in a water bath at 85°C until the yellow color of the 
solution disappears and store at 4°C (solution can be used for 14 
days) or at -20°C 
 
Protease inhibitors 
Complete EDTA-free inhibitor protease inhibitor cocktail tablets were 
purchased from Roche (Cat.Nr.: 11 873 580 001). 
1 tablet was dissolved in 1ml H2O 
 
Mixture for protein extraction  
Frackelton buffer  1ml 
 
Freshly added:  
    1mM PMSF   10μl 
    100μM Na3VO4  10μl 
    1mM DTT       1μl 
    Protease inhibitor  50μl 
 
 
 
Solutions for SDS-PAGE 
 
APS 20% (w/v) 
20g Ammoniumpersulfate solved in 100ml H2O 
store at -20°C 
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stacking gel (4%) 
0,5mL Acrylamide/Bisacrylamide-solution 
2,5mL H2O 
1ml stacking gel buffer (1,5M Tris-HCl pH 8,8) 
40µL 10 % SDS 
12µL TEMED 
12µl APS 
 
resolving gel                    7,5%  10% 
Acrylamide/Bisacrylamide-solution    2ml  1,3ml 
H2O          2ml     1ml 
stacking gel buffer (0,5M Tris-HCl pH 6,8)  4ml  1,7ml 
10 % SDS         80μl    40μl 
TEMED         24μl    12μl 
APS          24μl    12μl 
 
4x stacking gel buffer 
1,5M Tris HCl 
pH 8,8 
autoclave 
 
4x resolving gel buffer 
0,5M Tris-HCl 
pH 6,8 
autoclave 
 
10% (w/v) SDS 
dissolve 10g sodiumdodecylsulfate in H2O with gentle stirring and fill 
up to 100ml H2O 
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10x running buffer for SDS PAGE 
0,25M Tris 
1,92M glycin 
1% SDS (w/v) 
 
4x SDS sample buffer 
13,5ml H2O 
12,5ml 0,5M Tris HCl pH 6,8 
10ml Glycerol 
8ml 10% SDS 
4ml β-Mercaptoethanol 
2ml 0,05% (w/v) Bromphenolblaulösung 
 
 
 
Solutions for Western Blotting and protein detection 
 
Blotting buffer 
25mM Tris 
192mM Glycin 
15% Methanol 
10x TBST 
12g Tris 
88g NaCl 
5mL Tween 20 
add H2O to 1L 
pH 8 
 
Ponceau staining solution 
0,2% (w/v) Ponceau S 
3% (w/v) Trichloraceticacid TCA 
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TBST 
10mM TrisHCl pH 8,0 
150mM NaCl 
0,05% Tween 20 
 
Blocking solution 
10% milk in 1x TBST 
 
Stripping buffer 
200mM Glycin 
150mM NaCl 
0,05% Tween 20 
Add water to 1L 
pH 2,8 
autoclave the solution 
 
 
 
Reagents for cell death analysis 
 
10x Citratbuffer 
1,35M KCl 
0,15M NaCitrate 
autoclave and store at 4°C 
 
FACS buffer 
0,2% BSA 
0,2% sodium azide 
in sterile PBS 
filter sterilize 
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7.4 Antibodies 
 
 
antibody 
 
spezies 
 
dilution 
size 
(kDa) 
company 
Order 
number 
 
pan-ERK 
 
mouse 1:2000 42/44 BD Biosciences 610123 
 
IκBα (C-21) 
 
rabbit 1:1000 ~40 
Santa Cruz 
Biotechnology 
sc-371 
 
Stat1 C-Terminus 
 
rabbit 1:1000 84 (Kovarik P. et al, 1998) 
 
Phospho-Stat1 
(Tyr701) 
 
rabbit 1:1000 84/91 Cell Signaling 9171L 
 
Phospho-p38 
(Thr180/Tyr182) 
 
rabbit 1:1000 43 Cell Signaling 9215S 
 
p38α (N-20) 
 
rabbit 1:1000 43 
Santa Cruz 
Biotechnology 
sc-728 
 
p-AKT (Thr308) 
 
rabbit 1:1000 60 Cell Signaling 9275 
 
TBK1/NAK 
 
rabbit 1:1000 80 Cell Signaling 3013 
 
AKT1 
 
rabbit 1:1000 60 Cell Signaling 2967 
 
SAPK/JNK 
 
rabbit 1:1000 46/54 
New England 
Biolabs 
9252 
 
Phospo-SAPK/JNK 
(Thr183/Tyr185) 
 
rabbit 1:1000 46/54 
New England 
Biolabs 
9251S 
 
 
The antibodies were diluted in TBST with 2% BSA and 0,05% (w/v) 
NaN3 and stored at 4°C. 
For the detection of the primary antibody, anti-mouse antiserum 
conjugated to Alexa Fluor 680 (Invitrogen detection technologies, 
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Cat.Nr.:38879A) or IRDy800 (Rockland, Cat.Nr.: 610-132-121) or 
anti-rabbit antiserum conjugated to IRDye700DX or IRDy800 
(Rockland, Cat.Nr.: 611-130-122, 611-132-122) were used in a 
dilution of 1:20.000. 
 
 
7.5 Inhibitors 
 
 
 
Inhibitor 
 
inhibitory 
function on 
endconc. company 
order 
number 
 
BX795 
 
TBK1/IKKε 1μM Axon Medchem Axon 1390 
 
BIX02550 
 
IKKβ 6μM 
Boehringer-
Ingelheim 
- 
 
SB203580 
 
p38 4μM Sigma Aldrich S8307 
 
SP600125 
 
JNK 17,5nM Sigma Aldrich S5568 
 
 
All inhibitors were added to the cells one hour before infection or 
transfection and remained on the cells until the samples were taken. 
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7.6 Primer 
 
Primers for Reverse Transcription PCR 
 
InlAdown_for: 5’ - ACG CGT CGA CGC CAC TTC ATC TGT TGC AGG CTT A - 3’ 
InlAdown_rev: 5’ - ACA TCT AGC TCT TTA CAC TAC TTT ATA TAC ACT CCT TTT TCA ATA GT - 3’ 
 InlAup_for: 5’ - GCA AGA TCT AGG TTT AGG TGC AGT TAT CCG CGT - 3’ 
 InlAup_rev: 5’ - GCA AGA TCT AGG TTT AGG TGC AGT TAT CCG CGT - 3’ 
 bgal: 5' - CAT CTT CAT ACC AAA TTT CCT CTG G - 3' 
 InlAdownfor_Nco: 5’ – CAT GCC ATG GGC CAC TTC ATC TGT TGC AGG CTT A –3’ 
 down190_NcoI: 5´- CATG CCATGG TGC TGG AAC GAA CGA GAT GAA GGA - 3´   
 down_rev_lig: 5’ –CCA TAC ATA TCG TTT TTT TCT CAC TAT ATA CAC TCC TTT TTC AAT AGT-3’ 
 up_for_lig: 5’ – TAA AAA AGC ACG TGC TAG TAA ATA GAA GTA GTG TAA AGA GCT AGA TGT G-3’  
 InlAuprev_SalI: 5’ - CAG TGT CGA CAG GTT TAG GTG CAG TTA TCC GCG T – 3’ 
 up224_SalI: 5´- ACG CGT CGA CAT TTG CTT GAT TGG CGT TGG CAC G - 3´ 
 InlA_for_lig: 5’- ACT ATT GAA AAA GGA GTG TAT ATA GTG AGA AAA AAA CGA TAT GTA TGG-3’ 
 InlA_rev_lig: 5’- CAC ATC TAG CTC TTT ACA CTA CTT CTA TTT ACT AGC ACG TGC TTT TTT A-3’  
 InlA_AflII_for: 5’ – CGT GAC GCA GCC ACT TAA GGC AAT – 3’ 
 InlA_AflII_rev: 5’ - CAT GCC ATG GAT TGC CTT AAG TGG CTG CGT CAC G – 3’ 
 InlA_2_rev: 5’ – AAC TTG GTC TGG ATC CGT TTG TGA GAC – 3’ 
 InlA_3_for: 5’ – ATG AAC GCT TAG GAT CCT TAT AAT TCA – 3’ 
 Start_lig_rev: 5`-ATT ATA AGG GTC ATA AGC GTT CAT AAC TTG GTC TAG ATC TGT TTG TGA GAC-3’  
 Stop_lig_for: 5’-TCA CAA ACA GAT CTAGAC CAA GTT ATG AAC GCT TAT GAC CCT TAT AAT TCA-3’  
 down_rev: 5’ - TAT ATA CAC TCC TTT TTC AAT AGT -  3’ 
 up_for: 5’ – AAG TAG TGT AAA GAG CTA GAT GTG - 3’  
 InlA_for: 5’ – GTG AGA AAA AAA CGA TAT GTA TGG - 3’ 
 InlA_rev: 5’ – CTA TTT ACT AGC ACG TGC TTT TTT A - 3’ 
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Sequencing primers 
  
 InlAEGD_for1: 5’ – CAG GTG TAA CAA TCG GCG AA – 3’ 
 InlAEGD_rev1: 5’ – AGC GGG TCT ATA TCC GTT ATC TG – 3’ 
 InlAEGD_for2: 5’ – ACT TTC AAA GGC TGG TAT GAC GA – 3’ 
 InlAEGD_rev2: 5’ – ATC GTA TCG GTC TAA GGA AAG GTT – 3’ 
 InlAEGD_int1: 5’ – TCG TTT ACG TTG ACG TCT TCG GGT – 3’ 
 InlAEGD_int2: 5’ – GTG CCA CTT GCA GGT TTA ACT – 3’ 
 flInlA_3neu: 5’ – CAC AAC AAG TAC AAT GAA – 3’ 
 seqPrInlA5: 5’ – TGC CTG AGC ATT TGT CCC GTT ACT – 3’ 
 PCRInlALO28_for: 5’ – AAA TAC CAT AGG AAC AAT TCG TGG G – 3’ 
 PCRInlALO28_rev: 5’ – CGG TGA TAG TCT CCG CTT GTA CTT – 3’ 
 seqInlALO28_1: 5’ – CGC ATT ATC GCT ATC GCC AGT TGT – 3’ 
 seqInlALO28_2: 5’ – CCC AGC TTC CAC TTC TTT GGT TGT – 3’ 
 seqInlALO28_3: 5‘ – GGT TTG TTA AAC TCG CCA ATG TGC C – 3’ 
 seqInlALO28_4: 5’ – AGA ACC AAA GGC ACC AAC GAA AGC – 3’  
 seqinsert3: 5’ – CGC CGG AAG CGA GAA GAA TCA TAA – 3’ 
 seqinsert_1neu: 5‘ – CCG TTC AAG GAA TTC AGT ATT TAC CC – 3‘ 
 seqinsert_2neu: 5‘ – TTT GGC GGT AAG AGT GCG G – 3‘ 
 
Primers for control of the inlA knock-out 
 
 #1      seqInlALO28_1: 5’ – CGC ATT ATC GCT ATC GCC AGT TGT – 3’ 
 #2      seqInlALO28_4: 5’ – AGA ACC AAA GGC ACC AAC GAA AGC – 3’  
 #3      PCRInlALO28_for: 5’ – AAA TAC CAT AGG AAC AAT TCG TGG G – 3’ 
 #4      PCRInlALO28_rev: 5’ – CGG TGA TAG TCT CCG CTT GTA CTT – 3’ 
 #5      InlAEGD_for1: 5’ – CAG GTG TAA CAA TCG GCG AA – 3’ 
 #6      InlAEGD_rev1: 5’ – AGC GGG TCT ATA TCC GTT ATC TG – 3’  
 #7      InlAEGD_for2: 5’ – ACT TTC AAA GGC TGG TAT GAC GA – 3’  
 #8      InlAEGD_rev2: 5’ – ATC GTA TCG GTC TAA GGA AAG GTT – 3’  
 #9      pMAD_for630: 5’ – TCG CTA ACG GAT TCA CCA CTC CAA – 3’ 
 #10    pMAD_rev630: 5’ – TTG GTC ACT TGA TGC CTC CGT GTA – 3’ 
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Real Time Primers 
 
GAPDH_forward: 5’ - CAT GGC CTT CCG TGT TCC TA – 3’ 
 GAPDH_reverse: 5’ - GCG GCA CGT CAG ATC CA – 3’ 
 
 IFNb_forward: 5’ - TCA GAA TGA GTG GTG GTT GC – 3’ 
 IFNb_reverse: 5’ - GAC CTT TCA AAT GCA GTA GAT TCA – 3’ 
 
TAP1_forward: 5’- CTG GCA ACC AGC TAC GGG T – 3’ 
TAP1_reverse: 5’ – TGA GAA TGA GGA TGT GGT GGG – 3’ 
 
GBP2_forward:  5’ - TGC TAA ACT TCG GGA ACA GG – 3’ 
GBP2_reverse: 5’ - GAG CTT GGC AGA GAG GTT TG – 3’ 
 
IRF1_forward: 5’ – CCG AAG ACC TTA TGA AGC TCT TTG – 3’ 
IRF1_reverse: 5’ – GCA AGT ATC CCT TGC CAT CG – 3’ 
 
Mx2_forward: 5’ - CCA GTT CCT CTC AGT CCC AAG ATT – 3’ 
Mx2_reverse: 5’ – TAC TGG ATG ATC AAG GGA ACG TGG – 3’ 
 
 
 
7.7 Transfection reagents 
 
Opti-MEM® I reduced serum medium (Invitrogen) 
LipofectamineTM RNAiMAX (Invitrogen) 
PolyFect® Transfection Reagent (Quiagen) 
 
Poly(dA-dT) acid sodium salt (Sigma, Cat.No P0883-10UN) 
Poly(dA-dT) was used in a concentration of 1μg/μl.  
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siRNA:  ON-TARGETplus Non-targeting pool  
                  (Dharmacon, Cat.No D-001810-10-05) 
   
TBK1 ON-TARGETplus SMART pool 
   (Dharmacon, Cat.No L-063162-00-0010) 
 
siRNAs were used in a concentration of 2μM. 
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8 Methods 
 
8.1 Cell culture 
 
8.1.1 Culturing cell lines 
 
RAW 264.7 Macrophages 
This cell line was cultured in DMEM containing 10% of FCS. For 
splitting, the medium was sucked off, the cells were scraped in fresh 
medium and then seeded out into new 10cm dishes. These cells grow 
very fast. Therefore they have to be split 1:5-1:10 every second or 
third day.  
 
 
8.1.2 Isolation of bone marrow derived macrophages 
 
For the generation of bone marrow derived macrophages the femur 
and tibia of the hind legs of mice were isolated with scissors and 
forceps and put into PBS. 
The epiphyses were cut off and the bones were flushed with DMEM 
containing 10% FCS, 10-20% L-conditioned medium and Pen/Strep 
using a syringe with a needle of size 18. 
Bone marrow cells were cultivated in DMEM with 10% FCS, 10-20% 
L-conditioned medium and Pen/Strep on 10cm square dishes. The 
cells of one mouse were split to three to four dishes. The cells were 
fed every second or third day and after five to seven days they were 
split in a ratio of 1:2 or 1:3. 
The differentiated macrophages were used after 10-14 days in 
culture.  
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L-cell conditioned medium was generated in the lab. The L-cells were 
cultured in starvation medium without FCS for 10 days and then the 
supernatant was sterile-filtered. 
 
 
8.1.3 Freezing and thawing of bone marrow 
 
For freezing bone marrow, the bones were flushed as described 
before and centrifuged at 300g for 5-10min. The pellet was 
resuspended in a mixture of 500μl 10% dimethylsulfoxide (DMSO) 
and 90% DMEM. The cell suspension was transferred into a cryotube 
and stored at -80°C. 
For thawing, the frozen cells were warmed quickly and transferred 
into a tube containing DMEM. The cell suspension was centrifuged at 
300g, the pellet was resuspended in DMEM containing 10% FCS and 
10-20% L-cell conditioned medium and the cells were plated on 3-4 
10cm square dishes per mouse.   
 
 
8.1.4 Transfection of BMDM and RAWs 
 
For the siRNA transfection, 0,5x106 BMDM were seeded into 3,5cm 
tissue culture dishes. On the next day the transfection was 
performed. 250μl Opti-MEM® I reduced serum medium (Invitrogen) 
were mixed with 15μl siRNA (2μM) and 250μl Opti-MEM® I reduced 
serum medium were mixed with 5μl LipofectamineTM RNAiMAX 
(Invitrogen). The two solutions were combined, resuspended and 
incubated for 15min.  
The medium of the cells was changed and the siRNA duplex-
Lipofectamin complexes were added dropwise to the cells. 
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48h post transfection the medium was sucked off and replaced by 
2,5ml fresh medium. On the next day the cells were infected.  
 
For the transfection with poly(dA-dT), 106 RAW macrophages or 
1,6*106 primary macrophages were seeded into 6-well plates. Before 
adding the transfection reagents, the medium was reduced to 1,5ml. 
140μl DMEM, 10μl poly(dA-dT) (1μg/μl) and 25μl polyFect per sample 
were mixed, vortexed and incubated for 5min at room temperature. 
The solution was added dropwise to the cells. Samples were taken 2 
or 3 hours and 4 hours after transfection.  
 
 
 
8.2 Working with bacteria 
 
 
8.2.1 Cultivation of bacteria 
 
For the cultivation of Listeria monocytogenes 5ml of Brain-Heart 
infusion (BHI) medium purchased from BD (Cat.Nr.: 237200) were 
inoculated with a glycerol bacteria stock (stored at -80°C), and 
incubated over night at 37°C on a shaker. 
Escherichia coli was cultured in 5ml Luria Broth medium at the same 
temperature. 
The Escherichia coli strain DH5α, containing the temperature sensitive 
shuttle vector pMAD or pAUL-A, was incubated in 5ml Luria broth 
medium containing 100μg/ml ampicillin. 
Listeria monocytogenes strains, containing the plasmids pMAD or 
pAUL-A, were incubated in 5ml Brain-Heart infusion medium 
containing 3μg/ml erythromycin.  
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To determine the cell number, the optical density at 600nm was 
measured using a visible spectrophotometer from Amersham 
Biosciences. Thereafter the over night cultures were diluted 1:10 in 
the respective medium.  
For Listeria monocytogenes an OD600 of 1 is equivalent to 2x10
9 
bacteria/ml. 
 
 
8.2.2 Infection of cells with Listeria monocytogenes 
 
For infection experiments with Listeria monocytogenes, the host cells 
were seeded one day before onset of the experiment. 
Thereafter the medium containing Pen/Strep was sucked off and the 
cells were washed with sterile PBS. 4ml of medium without antibiotics 
were added to the dish and the cells were scraped off with a rubber 
policeman. The cells were pooled and counted in a 1:10 dilution, 
using the Vi cellTM cell viability analyzer (Beckman Coulter). 
The respective amount of cells was seeded in medium without 
Pen/Strep and incubated over night. 
On the next day the cells were infected with the appropriate amount 
of an over night culture to get a multiplicity of infection (MOI) of 10-
30, according to the requirements.  
One hour after infection the medium was replaced by medium 
containing 50μg/ml gentamycin to kill all the extracellular bacteria, 
which were not taken up by the cells. After an additional hour the 
medium was again sucked off and medium containing 10μg/ml 
gentamycin was added. 
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8.2.3 Generating competent bacteria 
 
Escherichia coli 
To obtain competent DH5α bacteria, an O/N-culture was diluted 
1:100 and the bacteria were incubated at 37°C until they reached an 
OD between 0,35 and 0,4. The cellsuspension was centrifuged at 
approximately 4700g for 15min at 4°C and the pellet was 
resuspended in 10ml 100mM CaCl2 solution. The cells were incubated 
for 20min on ice and then they were again centrifuged for 15min at 
4692g and 4°C. The pellet was resuspended in 2ml 100mM CaCl2 
solution with 15% Glycerol, aliquoted in 100μl and frozen at -80°C.  
 
Listeria monocytogenes 
2ml of an overnight culture of Listeria monocytogenes were used to 
inoculate 100ml of BHI medium containing 0,5M sucrose. The cells 
were incubated on a shaker at 37°C until they reached an OD600 of 
about 0,2. 
Ampicillin was added to the culture to get a final concentration of 
10μg/ml and the bacteria were again incubated on a shaker at 37°C 
for two more hours. Then the culture was centrifuged at 7000rpm for 
10 minutes at 4°C. All the following steps were carried out with cold 
solutions and on ice. The supernatant was poured off and the pellet 
was resuspended in 90ml 1mM Hepes (pH 7) containing 0,5M 
sucrose. 
The centrifugation step was repeated and the pellet was again 
washed with 45ml Hepes/sucrose solution. Finally the suspension was 
centrifuged one last time, the pellet was resuspended in 400μl 
Hepes/sucrose, aliquoted into 100μl and stored at -80°C.  
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8.2.4 Transformation of bacteria 
 
Escherichia coli 
For transformation, the plasmid and 100μl of the competent DH5α 
cells, which were thawed on ice, were mixed. They were incubated for 
15-30min on ice, transferred 1min to 42°C in a waterbath and placed 
for 2min on ice again. 1ml LB was added, the cell suspension was 
transferred into a round bottom tube and incubated for about 1 hour 
at 37°C. 100μl of the cell suspension were plated onto an LB dish 
containing 500μg/ml erythromycin. 
 
Listeria monocytogenes 
For electroporation a 0,2cm electorporation cuvette was washed with 
water and ethanol and dried at 70°C for some minutes. Remaining 
DNA was crosslinked to the cuvette for 2 times with 360 Joule using 
the UV Stratalinker 2400 from Stratagene.  
About 1μg of plasmid was added to competent Listeria 
monocytogenes cells and the electroporation was accomplished with a 
Gene pulser (BioRad) under the following conditions: 
1,5kV/400Ω/25μFD and a pulse duration of about 5ms. 
1ml of BHI medium containing 0,5M sucrose was added and 
incubated for two hours at 30°C for temperature-sensitive plasmids 
or for 1 hour at 37°C without shaking. 
100μl of the electroporated culture were plated on a BHI agarose 
plate containing the appropriate antibiotic and incubated at the 
proper temperature. The colony formation took about 2-3 days.  
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8.3 Recombinant DNA technology 
 
 
8.3.1 Plasmid DNA purification 
 
The plasmid DNA purification was accomplished by using the 5prime 
PerfectPrep Spin Mini Kit of Eppendorf (Cat.Nr.: 2300110) according 
to the instructions. The plasmid was eluted with 50μl of DNAse free 
water and the concentration was measured with a Nano-Drop system.  
 
 
8.3.2 Polymerase chain reaction (PCR) 
 
For the polymerase chain reactions, proof-reading DNA polymerases 
were used (PFU, Fermentas; AccuPol, Ampliqon).  
The mastermixes were prepared as follows: 
 
             5μl         buffer-MgSO4 (10x) PFU or 
       ammonium reaction buffer (10x) AccuPol  
         4μl  MgSO4 for PFU polymerase 
              1μl  10mM dNTPs 
          1μl  forward primer (100pmol/μl) 
             1μl  reverse primer (100pmol/μl) 
             *μl  template DNA 
        1μl  Pfu or AccuPol 
      _____  H2O 
     50μl 
 
* depending on the concentration of the DNA 
 
The PCR was performed with the following program: 
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1x   95°C for 5min 
30x    95°C for 30sec 
               * for 30sec (primer annealing) 
    72°C for * sec  (Pfu extention time 2min/kb) 
1x   72°C for 7min 
 
* Primer annealing temperature depends on the primer length and 
the A-T/G-C percentage. The extention time depends on the length of 
the DNA fragment that should be amplified. The extention time for 
the Fermentas proof reading polymerase is about 2min per kilobase, 
for the Ampliqon AccuPol about 1-2 kilobases per minute.  
 
 
8.3.3 Phenol-Chloroform extraction 
 
5ml of an O/N culture were centrifuged at 8000rpm and 4°C for 
10min. The pellet was resuspended in 500µl TE buffer, 25µl of 
lysozyme (50mg/ml) were added and incubated at 37°C for 30-40min 
on a shaking heating block. 
120µl 0,5M EDTA, 160µl 10% SDS and 50µl RNAseA (10mg/ml) were 
added and again incubated under the same conditions. 
20µl of proteinaseK (20mg/ml) were added and incubated at 37°C for 
30min with occasional tumbling to mix the suspension. 1 volume 
(about 875µl) of phenol:chloroform:isoamylalcohol (25:24:1) were 
added to the extract and strongly mixed. The emulsion was 
centrifuged at 15000rpm at room temperature for 10min and the 
upper phase was carefully transferred into a new sample tube. The 
last step was repeated at least once, until there was no white layer at 
the interface. 
1 volume of chloroform (about 400µl) was added and again mixed 
well. The centrifugation was repeated and the upper phase was 
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transferred into a new sample tube. To each tube, 2 volumes of 
100% EtOH were added, gently mixed by inverting the tube several 
times, centrifuged at 15000rpm at room temperature for 10min and 
the supernatant was carefully removed. The pellet was washed with 
70% ethanol and air-dried. Finally the DNA was resuspended in 50µl 
sterile H2O and stored at -20°C. 
 
 
8.3.4 Precipitation of DNA 
 
One volume of isopropanol was added to the sample and incubated at 
-20°C for 30 minutes to 1 hour. Then the tube was centrifuged at 4°C 
and maximum speed in a table top centrifuge.  
The pelleted DNA was washed with 500μl 70% EtOH and dried at 
55°C on a heating block for some minutes. Then 30-50μl of DNAse-
free water were added and the sample was again inucubated at 55°C 
up to one hour and finally resuspended.  
Concentrations were mesuared with a Nano-Drop system.  
 
 
8.3.5 Agarose gel electropheses and extraction of DNA 
 
For the agarose gel electrophoreses a 0,7-1% Bioyzme LE Agarose 
gel (2% for very small DNA fragments) was used, containing 
0,5μg/ml ethidiumbromide. The gels were run at 80-110V in TAE 
buffer. 
DNA was extracted using the 5prime DNA extraction kit from 
Fermentas according to the manufacturer‘s protocol. DNA was eluted 
with RNAse/DNase free water and measured with a Nano-Drop 
system.  
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8.3.6 Purification of PCR products 
 
For DNA purification the 5prime Perfect Prep Spin Mini Kit (Eppendorf, 
Cat.Nr.: 2300600) was used. All the steps were performed following 
the manufacturer‘s manual. 
DNA was eluted using 30-50μl of DNAse free water.    
 
 
8.3.7 Restriction digest 
 
Restriction digests were usually performed with 5% restriction 
enzyme in the mastermix.  
For double digests the following buffers were used.  
 
SalI   
buffer O+ 
BglII   
SalI   
2x Tango 
NcoI 2-fold excess 
BamHI   
1x Tango 
NcoI   
BamHI   
buffer BamHI 
SalI 2-fold excess 
BglII   
2x Tango 
BamHI 2-fold excess 
 
All restriction enzymes were purchased from Fermentas. 
The restriction digest was accomplished at 37°C for 1-3 hours or at 
16°C over night. For incubation longer than one hour, additional 
enzyme was added after 1 or 1,5 hours.  
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8.3.8 Ligation 
 
For ligation of DNA fragments a T4 ligase, purchased from Fermentas, 
was used.  
The ligation was accomplished at 22°C for 1 hour or at 16°C over 
night. The enzyme was inactivated by heating to 65°C for 10min.  
 
 
 
8.4 Colony forming units (CFU) assay 
 
For the CFU assays 5x104 BMDM cells per well were seeded in a 96-
well plate in medium without Pen/Strep. 
The cells were infected with Listeria monocytogenes LO28 at an MOI 
of 10. 
After 2 hours the medium was replaced by prewarmed medium 
containing 50μg/ml gentamycin and after an additional hour the 
medium was again exchanged by medium containing 10μg/ml. 
The inoculum was serially diluted 1:10 and the dilutions with about 
10, 100 and 1000 bacteria were plated on BHI plates for the 
calculation of the real MOI.  
For each timepoint the medium was sucked off, the cells were washed 
with 100µl sterile PBS for two times, 100μl sterile H2O were added 
per well and resuspended to detach the cells. The cell lysats were 
transferred into sample tubes, again 100μl sterile H2O were added, 
resuspended and transferred in the same sample tube.  
The cell lysates were diluted 1:10 and 100μl of the dilutions with an 
expected value of 10-10.000 bacteria were plated out.  
The BHI plates were incubated at 37°C over night and on the next 
day the colonies were counted.    
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8.5 Analysis of proteins 
 
8.5.1 Protein extracts 
 
For the protein extracts 1,5x106-2x106 macrophages were seeded out 
one day before on 6-well plates or 6cm tissue culture dishes (Nunc). 
The cells were infected with Listeria monocytogenes LO28 at an MOI 
of 10 or 20. 
All the following steps were performed on ice and in the presence of 
protease inhibitors and vanadate to prevent dephosphorylation of 
proteins. 
The medium was sucked off and the cells were washed with cold PBS, 
which was then completely sucked off.  80μl of the Frackelton buffer, 
including the other reagents (see chapter 7.3; solutions for protein 
isolation), were added and the cells were scraped off with a cell 
scraper, and transferred into a reaction tube. The cells were 
centrifuged for 5min at 12.000rpm and 4°C in a table top centrifuge 
and the supernatant was transferred into a new Eppendorf tube. 30μl 
of SDS sample buffer were added. The solutions were mixed and 
cooked for 5-10min at 95°C on a heating block and stored at -20°C.  
 
 
8.5.2 SDS-PAGE (polyacrylamid gel electrophoresis) 
 
The separating gel was poured and overlaid with waterlogged 1-
butanol to get a straight and air bubble free surface. After 
polymerization, the alcohol was removed, the stacking gel was 
poured and the combs were immediately inserted.  
The polymerized gels were fixed in the electrophoresis apparatus and 
running buffer was added. 5μl of protein marker (Page ruler 
prestained protein ladder (Cat.Nr.: SM0671) or Page ruler plus 
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prestained protein ladder (Cat.Nr.: SM1811), purchased from 
Fermentas) and 20-30μl of the thawed samples were loaded onto the 
gel.  
The gels were run at 80-90V until the proteins passed the borderline 
between the stacking gel and the separating gel. Then the voltage 
was increased to about 110. 
 
 
8.5.3 Western Blotting 
 
For western blotting we used a semi-dry transfer cell from Biorad. 
The separating gel and the blotting paper (BioRad, Protean® xi size) 
were equilibrated in the blotting buffer for some minutes and the 
nitrocellulose membrane (Optitran BA-S83 reinforced NC, Schleicher 
and Schuell) was equilibrated in water. 
The blotting sandwich was assembled in the following way: 
 
Anode (+) 
Blotting paper 
Nitrocellulose membrane 
Separating gel 
Blotting paper 
Cathode (-) 
 
Air bubbles were removed and the blotting was performed at 32mA 
per gel for 1,5 hours. 
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8.5.4 Immunostaining 
 
For immunostaining of the membranes the antibodies listed in 
chapter 7.4 were used.  
 
After blotting, the membranes were stained with Ponceau S for some 
minutes to ensure the protein transfer. Then the membrane was 
rinsed with water and blocked with TBST containing 10% of non fat 
milk powder for 30 minutes. 
After the blocking, the membrane was washed three times with TBST 
for 10 minutes. 
Then the primary antibody solution was added and incubated over 
night at 4°C (or at room temperature for 1 to 2 hours) on a shaker. 
On the next day the antibody solution was transferred back to a 
falcon tube and stored at 4°C for reuse. The membranes were 
washed again three times with TBST for 10 minutes and then the 
secondary antibody, coupled with a fluorescence dye and diluted 
1:20.000 in TBST, was added and incubated for 1 hour at room 
temperature protected from light.  
After the incubation, the membrane was again washed 3 times for 10 
minutes with TBST and finally the membrane was analysed with an 
Odyssey scanner. 
  
 
8.5.5 Stripping of the membrane 
 
Nitrocellulose membranes can be reused for detection of other 
proteins with a different antibody.  
For this purpose the membrane has to be stripped. The membrane is 
shortly rinsed with water and then stripping buffer is added for about 
10 minutes. After the incubation on the shaker the membrane is 
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again rinsed with water and the immunostaining procedure, including 
the blocking step and all the washing steps, can be repeated.  
  
 
8.6 Analysis of mRNA levels 
 
8.6.1 RNA extraction of whole cell lysates 
 
For the RNA extracts 1x106 macrophages were seeded one day before 
the infection in 6-well plates (Nunc, Cat.Nr.:140675).  
On the next day they were infected with Listeria monocytogenes 
LO28 according to the procedure described in chapter 8.2.2 with an 
MOI of 10. 
The medium was sucked off and the macrophages were washed with 
ice-cold PBS. 
The cells were scraped in 400μl RA1 lysis buffer (Nucleospin RNA II 
kit, Macherey and Nagel) containing 4μl of β-mercapthoetanol, 
transferred into a reaction tube and stored at -80°. 
For the further RNA preparation, the Nucleospin RNA II kit was used 
according to the manufacturer‘s instructions.  
The RNA was eluted with 60μl of RNAse free water. 
 
 
8.6.2 Preparation of cDNA from RNA samples 
  
For the reverse transcription approximately 1μg of RNA was used and 
filled up to 10μl with RNAse free water.  
1μl of oligo dT primer was added and the mixture was incubated for 5 
minutes at 70°C. Then 4μl 5x reaction buffer (Fermentas), 2μl 10mM 
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dNTPs and 2μl RNAse free water were added and incubated for 5 
minutes at 37°C.   
1μl of Reverse Aid Reverse Transcriptase (Fermentas) was added and 
the cDNA was generated in 1 hour at 42°C. The reverse transcriptase 
was inactivated for 10 minutes at 70°C.  
For real time PCR the cDNA samples were further diluted 1:10 in 
RNAse free water and stored at -20°C.  
 
 
8.6.3 Real Time PCR with Sybr Green 
 
For real time PCR experiments an iCycler IQ real time PCR machine 
(Biorad) or a Mastercycler® ep realplex (Eppendorf) were used.  
Sybr Green is a dye, which intercalates into double stranded DNA and 
can be measured at 490nm. 
For the normalisation of the gene of interest the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was amplified.  
The Sybr Green was diluted 1:20 in DMSO and stored at -20°C. This 
solution was further diluted 1:100 in RNAse free water. The final 
dilution needs to be prepared freshly. 
As a calibration dye FITC (purchased from Biorad, 1mM) was used in 
a dilution of 1:1000 in RNAse free water.The dilutions have to be 
stored in a light protective reaction tube at -20°C.  
The real time PCRs were performed using the Redmix (ampliqonIII, 
Cat.Nr.: 52003009G14 ), which already contains the polymerase.  
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The PCR mastermix was prepared as following: 
 
   12,5μl  Redmix (2x) 
     0,1μl forward primer (100pmol/μl) 
     0,1μl reverse primer (100pmol/μl) 
   0,25μl FITC (1:1000) 
        1μl Sybr Green (1:2000) 
   6,05μl RNAse/DNAse free water 
        5μl template DNA 
      25μl 
 
The PCRs were performed with the following programmes: 
 
I cycler: 
 
1x  95°C for 3min 
40x  95°C for 10sec 
    60°C for 15sec 
    72°C for 15sec 
1x   95°C for 1min 
80x  60°C + for 10sec  
 
Real Plex (Eppendorf): 
 
  1x  95°C for 4min 
  40x  95°C for 15sec 
    60°C for 15sec 
    68°C for 20sec 
  1x   95°C for 15sec 
  80x  60°C-95°C for 15sec 
  1x  60°C for 2min 
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8.7 Cell death analysis 
 
8.7.1 Propidium iodide (PI) staining  
 
5x105-1x106 cells were seeded one day before infection on 6-well 
plates, 3,5cm tissue culture dishes or 6cm tissue culture dishes.  
The cells were infected with an MOI of 10 to 30.  
In preparation for the PI staining, 1ml PBS was added to a FACS tube 
(BD Falcon, Cat.Nr.: 352052).  The medium of the cells, which could 
contain dead cells, was transferred to the tube with the PBS. 
An appropriate volume of the 10x stock solution of citrate buffer was 
diluted 1:10 with sterile water and 1ml of the prewarmed (37°C) 
dilution was added to each well/plate and incubated at 37°C for a 
maximum of 5 minutes.  
The cells were detached by pipetting up and down for several times 
and also transferred to the same FACS tube.  
The cell suspension was centrifuged for 10 minutes at 300g and 4°C 
and the supernatant was sucked off. The pellet was washed with 1ml 
FACS buffer and again centrifuged under the same conditions. 
Finally the cell pellet was resuspended in 500μl FACS buffer. 
Directly before flow cytometric analysis 5μl of PI with a concentration 
of 500μg/ml were added.  
The FACS experiments were performed with a FACSCalibur (BD 
Biosciences). 
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